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ABSTRACT
A Study on the Hormonal Regulation and Novel Role of Na+ Leak Channel, Non-Selective
(NALCN) in Human Myometrial Smooth Muscle Cells
by
Chinwendu Laura Amazu
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Cell Biology
Washington University in St. Louis, 2022
Professor Sarah K. England, Chairperson
During pregnancy, the uterus transitions from a quiescent state to an excitable, highly
contractile state to deliver the fetus. Two important contributors essential for this transition are
progesterone (P4) and estrogen (E2), which promote quiescence or contraction, respectively, by
acting on the myometrial smooth muscle cells (MSMCs). While these hormones regulate uterine
contractions, it is unclear how they affect electrical activity of MSMCs, which underlies uterine
contractile activity. Our lab recently identified Na+ leak channel, non-selective (NALCN) as a
component of the leak current in human MSMCs and showed that mice lacking NALCN in the
uterus have dysfunctional labor. In this thesis, we first sought to determine whether P4 and E2
directly regulated NALCN expression and activity. We established that P4, upregulates the
expression of NALCN by acting through progesterone response elements in the NALCN
promoter while E2 downregulates this channel in humans MSMCs. These expression changes
translated functionally as P4 significantly enhanced, and E2 significantly inhibited a NALCNdependent leak current in human MSMCs. Our findings that NALCN is upregulated by P4, a
pro-quiescent hormone: 1) contradicts the traditional concept that Na+ influx depolarizes the cell
to enhance cell excitability and 2) provides a novel role for Na+ entry through NALCN. Thus, we
x

further explored if Na+ influx through NALCN may contribute to promoting quiescence by
activating other signaling pathways. We provide evidence that current through NALCN is a
source of Na+ to activate SLO2.1, the Na+-activated K+ channel, which contributes to the resting
membrane potential (Vm) of MSMCs. Additionally, we observed that SLO2.1 was in proximity
with NALCN in human MSMCs and our data suggests these channels form a functional complex
to maintain Vm and modulate intracellular Ca2+ levels. Overall, our findings identified a new
form of regulation of NALCN in human MSMCs and unmasked how NALCN contributes to Vm
in order to regulate myometrial excitability.

xi

Chapter 1: Introduction
1.1 Pregnancy and Labor
Human pregnancy is divided into three trimesters each lasting approximately three
months. The first trimester represents the first 12 weeks of pregnancy and starts with conception,
which is when the sperm fertilizes the egg. It is also a critical time for the development of the
fetus’ body structure and organs. The second trimester, which lasts from 13 to 28 weeks, is the
time when the fetal organs fully develop. Finally, in the third trimester as fetal development
continues, the body of the fetus increases in size and weight in preparation for delivery, which
occurs at ~40 weeks [1, 2]. In order to adapt to these changes in fetal growth and development,
pregnancy requires behavioral, cardiovascular, hormonal, metabolic, renal, hematologic,
respiratory, and reproductive adaptations in the mother.
A key adaptation of pregnancy is the remodeling of the uterus. First, there is an increase
in uterine size from 40-70 grams in the non-pregnant state to 1100-1200 grams by the end of
pregnancy [3]. Uterine growth occurs through both hypertrophy and hyperplasia of smooth
muscle cells within the uterus, which help to accommodate the growing fetus for the majority of
pregnancy and increases mechanical stretch to prepare for parturition at the end of pregnancy [4].
Second, there is a 3.5-fold increase in blood volume of the mother from non-pregnant to late
gestation [5]. For this to occur, the uteroplacental spiral arteries go through a series of changes,
including replacing the muscular media and the endothelium. These changes reflect the
development and growth of the uteroplacental circulation, which fulfill the metabolic needs of
the fetus during gestation. Third, the uterus undergoes autonomic denervation, showing a loss of
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adrenergic and cholinergic innervation [6]. Overall, these three major adaptations of the uterus
allow for successful growth, maturation and delivery of the fetus.
The growth, remodeling and adaptations that occur during pregnancy culminate with
labor; the delivery of the fetus and the placenta. Labor is divided into three stages: 1) onset of
labor where the cervix fully dilates, 2) delivery of the fetus, and 3) delivery of the placenta and
membranes. Contractions of the uterus occur throughout pregnancy, however at the time of
labor, contractions increase in frequency and intensity for successful delivery of the fetus and the
placenta [7]. However, we still lack full understanding of the molecular and physiological
mechanisms that underlie successful pregnancy and labor.
Many adverse pregnancy outcomes are associated with dysfunctional uterine
contractions. For example; uterine tachysystole, defined as more than five contractions in a ten
minute period averaged over a 30-minute window [8] occurs in 10-50% of labors and is
associated with fetal acidemia [9], decreased fetal oxygen saturation, and deterioration in the
fetal heart patterns [10]. Babies from deliveries complicated by tachysystole have higher rates of
Neonatal Intensive Care Unit admission and neonatal sepsis [11]. Another type of aberrant
uterine activity is dystocia, where the uterus does not efficiently contract during parturition.
Dystocia is associated with a higher risk of stillbirth or perinatal death [12] and is the leading
indication for primary cesarean delivery in the United States [13]. The last 40 years have seen an
exponential increase in the rate of cesarean deliveries: in 2018, 31.9% of infants born in the US
were delivered by cesarean section, a high rate that is inversely correlated with the rate necessary
for maintaining the lowest infant and maternal mortality [14, 15]. The final type of aberrant
uterine activity is preterm labor, or pathological contractions that occur prior to 37 weeks of
gestation [16]. About 67% of preterm birth are spontaneous labor, while the remaining are
2

medically indicated due to maternal or fetal complications, such as preeclampsia or growth
restriction [17]. Each year, fifteen million babies are born preterm with global rates ranging from
5% to 18%, with the highest burden in North America and Africa [18]. A significant public
health issue; preterm birth is the leading cause of neonatal death and the second cause of
childhood death below 5 years old [19]. Those born preterm have higher rates of health and
developmental problems that persists into adult life [20]. In the United States, the annual
economic burden associated with preterm birth is at least $26.2 billion and rising [21].
Many health agencies, including the Society for Maternal-Fetal Medicine, Centers for
Disease Control and Prevention, American College of Obstetricians and Gynecologists and
World Health Organization, are focusing their efforts on the reduction of preterm births and
cesarean deliveries, in part, by advocating for more research aimed at understanding normal
labor progression [22]. Yet, progress has been hindered primarily due to our incomplete
understanding of uterine physiology. It is therefore vitally important for maternal-fetal health
that we continue to study the mechanisms of uterine quiescence and contractility that govern
both normal and pathological labor.

1.2 Uterine Anatomy and Physiology
1.2.1 Uterine Anatomy
The uterus is a “pear-shaped organ” that has a rounded upward component containing the
fundus and the body of the uterus and a lower, elongated end forming the cervix. The uterus is
comprised of three layers: 1) the serosa, which is a continuation of the peritoneal epithelium and
covers the outer surface of the uterus, 2) the endometrium, which covers the inner surface of the
uterus and is the site of implantation and placentation, and 3) the myometrium, which is the
muscular layer that lies between the serosa and endometrium. The myometrium is divided into
3

three layers: 1) the stratum submucosum composed of primarily longitudinal smooth muscle
fibers, 2) the stratum vasculare, which consists of circular smooth muscle and 3) the stratum
subserosum, which contains large longitudinal smooth muscle fibers [23, 24]. The smooth
muscle of the stratum submucosum coordinates the endometrial movements (subtle contractions)
observed in the menstrual cycle while the myometrial smooth muscle cells (MSMCs) of the
stratum subserosum facilitate the excitation-contraction coupling that induces the large uterine
contractions that occur during parturition [24, 25].

1.2.2 Regulation of Myometrial Activity
Contractile Activity
In MSMCs, the excitation-contraction coupling cascade begins when intracellular Ca2+
ions bind to calmodulin, a Ca2+-dependent cytosolic protein [26]. This complex activates myosin
light chain kinase (MLCK) to increase phosphorylation of myosin light chain MLC 20, the
regulatory subunit of the myosin filament [27]. Myosin thick filaments are composed of two
regulatory light chains and two heavy chains. The heavy chains contain a head region containing
an ATPase domain, which produces energy required for the contractions and actin-binding
domain. Once MLC20 is phosphorylated, the ATPase domain hydrolyzes ATP and the angle of
the myosin heads are more aligned with the actin filaments. Myosin thick filaments pull the actin
filaments towards the center of the cell, shortening the MSMC. Myosin then releases ADP, binds
new ATP, and gets released from the actin, in order to start the cycle again [28].

Hormonal Regulation
Uterine contractile status during pregnancy is mediated in part by the actions of two sex
steroid hormones, progesterone (P4) and estrogen (E2). Progesterone and E2 signal primarily
4

through their respective nuclear receptors, a family of ligand-regulated transcription factors [2931]. Both hormones can freely cross the cell plasma membrane and bind to their respective
receptors, and once activated, can regulate the transcription of various genes including those
associated with uterine contractile status [31]. Progesterone and E2 can also function at nongenomic levels by activating membrane localized and G-protein coupled steroid receptors [32,
33].
Progesterone’s actions are primarily mediated by its binding to two classical nuclear
receptor isoforms, PR-A (94 kDa) and PR-B (114 kDa), produced by alternative transcription
and translational initiation from a single gene, PGR [34, 35]. The PR-A and PR-B isoforms have
opposing actions on myometrial contractility: PR-B dominates throughout pregnancy and
maintains myometrial quiescence while PR-A is functionally dominant at term and promotes
contraction [34]. Progesterone bound to PR-B maintains uterine quiescence by direct and indirect
mechanisms. The P4-PR-B complex directly binds to progesterone response elements (PRE) of
contractile or proinflammatory genes to inhibit transcription [36]. For example, P4-PR-B directly
represses, the oxytocin receptor (OXTR), connexin-43 (GJA1), proinflammatory gene
cyclooxygenase 2 (PTGS2), nuclear factor kappa B subunit (NFKB1) and interleukin-6 (IL6), all
genes which are known to promote contraction (Figure 1.1A) [37-39]. In addition to direct
binding to PREs, the P4-PR-B complex blocks the binding of transcription factors that
upregulate these genes, while inducing expression of transcription factors that promote
quiescence. For example, P4-PR-B inhibits the binding of nuclear factor kappa B (NF-κB) and
activator protein 1 (AP-1) to promoters of genes such as PTGS2, OXTR, and GJA1 (Figure 1.1B)
[40-42]. In addition, P4-PR-B increases the expression of three transcriptional regulators: IκBα, a
crucial inhibitor of NF-κB activation, ZEB1 and ZEB2 [40, 43-45].
5

Figure 1.1: Hormonal Regulation of Uterine Quiescence during Pregnancy
A) P4-PR-B complex binds to the PRE promoter region and directly downregulates the
transcription of OXTR, PTGS2, GJA1 and IL6. B) P4-PR-B complex indirectly downregulates
the transcription of contractile and pro-inflammatory genes by upregulating IκBα and reducing
NFκB activity and upregulating ZEB1/2 expression to decrease expression of OXTR, GJA1 and
miR-200. C) The mPRs bound to P4 signal through PR-B to promote P4-PR-B complex
transcriptional activity.
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The P4-PR-B complex causes rapid induction of IκBα mRNA and protein expression and blocks
degradation of IκBα by the proteasome [40, 46]. With the upregulation of IκBα, more NF-κB is
sequestered in an inactive state, further inhibiting transcription of PTGS2, OXTR, and GJA1
(Figure 1.1B). ZEB1 and ZEB2 downregulate the transcription of OXTR and GJA1 by directly
binding to their promoters or indirectly by inhibiting the expression of miR-200 family,
microRNAs that upregulate OXTR and GJA1 (Figure 1.1B) [45, 47]. Additionally, the membrane
localized progesterone receptors (mPRα and mPRβ) signal through the P4-PR-B complex to
promote uterine quiescence [48]. Specifically, P4 bound to mPRs activates Gᵢ protein alpha
subunit and increases PR-B transcriptional activity (Figure 1.1C) [48].
In most mammals including mice, parturition is initiated by a decrease in circulating P4
levels transitioning the myometrial cells from a quiescent to a contractile state. However,
humans do not exhibit a decrease in serum P4 at term, but instead become less sensitive to P4,
termed a “functional progesterone withdrawal.” This occurs through several potential
mechanisms: 1) increased expression of specific endogenous PR antagonists, such as proteinassociated splicing factor (PSF) [49], 2) decline in the levels of PR-associated co-regulators [50],
3) increased expression of the P4 metabolizing enzyme, 20α-hydroxysteroid dehydrogenase
(HSD) [51] and/or 4) increased PR-A expression, leading to an increased PR-A/PR-B ratio
(Figure 1.2A) [39, 52, 53].
PR-A, the pro-contractile PR isoform, acts as a dominant negative to repress the genomic
and non-genomic pro-quiescent mechanisms of PR-B [54-57]. Pro-inflammatory molecules such
as IL-1β and prostaglandin-F2α increase the abundance and stability of PR-A, which contributes
to the functional withdrawal observed at term (Figure 1.2B) [52, 58, 59].
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Figure 1.2: Hormonal Regulation during the Contractile Period of Pregnancy
A) The increase in PR antagonists (PSF), 20α HSD and PR-A leads to PR-B functional
withdrawal at term. B) The increase in PGF-2α and IL-1β enhances PR-A stability and
upregulation of GJA1. C) Due to the decline of PR-B function, the crosstalk between mPRs and
PR-B is inhibited allowing for mPR and Gi/o contractile pathway. D) ERα activity increases leads
to: 1) direct upregulation of OXTR, PTGS2 and GJA1 and downregulation of ZEB1/2 and 2)
indirect upregulation of OXTR by activation of ERK/MAPK pathway.
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Additionally, increase of 20α HSD decreases local P4, leaving many nuclear PR-A receptors
unliganded. At term, unliganded PR-A transcriptionally activates GJA1 to promote a contractile
environment (Figure 1.2 B) [53]. Finally, at a non-genomic level, with the decrease in PR-B,
activated mPRs can no longer transactivate PR-B. These events allow P4 to act primarily on the
mPRs during labor, to evoke responses such as inhibition of adenylyl cyclase and
phosphorylation of myosin light chain (Figure 1.2C). This also sensitizes the myometrium
toward a more contractile state at term [48].
Estrogen binding to estrogen receptor α (ERα) promote myometrial contractility as
pregnancy progresses to term by signaling through both classical and the non-classical pathways.
Classically, E2 bound to ERα results in direct binding to estrogen response elements (EREs) and
increases transcription of downstream genes including OXTR, CX43 and COX-2 (Figure 1.2 D)
[51, 60-62]. E2 also downregulates ZEB1 and ZEB2 expression, which indirectly upregulates
pro-inflammatory genes like COX-2 (Figure 1.2D) [47]. COX-2 catalyzes the production of
prostaglandins to initiate labor [63]. In the non-classical pathway, E2 bound to ERα can also
activate the extracellularly regulated kinase/mitogen-activated protein kinase (ERK/MAPK)
pathway to indirectly upregulate the transcription of OXTR gene (Figure 1.2D) [64].
The increase in ERα signaling and enhanced uterine stretch caused by the growing fetus
also provide an important stimulus for the initiation of labor [65, 66]. These factors stimulate an
inflammatory response, invasion of the myometrium by neutrophils and macrophages, and an
increase in levels of proinflammatory cytokines in the amniotic fluid [67-70]. The release of
chemokines and cytokines by invading immune cells causes activation of many inflammationassociated transcription factors including NF-κB and AP-1 as well as an increase in ERα [71-73].
These key players promote increased expression of myometrial pro-inflammatory genes (e.g. IL9

1β and IL-8) and genes of contractile-associated proteins (OXTR, CX43 and COX2) [41, 42, 74,
75].

Electrical Basis of Myometrial Contractile Activity
The electrical activity of MSMCs, which underlies uterine contractions, are caused by
specific changes in membrane permeability to Ca2+, K+, Na+ and Cl- ions, which result from
changes in both expression and activity of various ion channels, ion transporters, pumps and
exchangers [76, 77]. A balance of K+ efflux and Na+ influx through K+ leak currents and inward
rectifying K+ channels or Na+ leak currents, respectively, primarily sets the negative resting
membrane potential (Vm) in human MSMCs [76, 78]. In these cells, the Vm has been recorded at
~-75 millivolts (mV) at week 28 of pregnancy, closer to the K+ equilibrium potential [79]. By
the end of pregnancy, the Vm steadily depolarizes (more positive Vm) to ~ -40 mV at term [79].
The MSMC action potential underlies control of uterine contractions and are comprised
of three phases: 1) the slow upstroke and depolarization 2) repolarization and 3) the slow
pacemaking phase [80-83]. The upstroke is primarily due to Ca2+ influx through L-type Ca2+
channels, which are activated at ~-40 mV in MSMCs [84, 85]. These channels are slow to both
activate and inactivate [86]. This allows the channels to be open for ten to hundred milliseconds,
which allows the sustained plateau of depolarization characteristic of MSMCs and uterine
contractions [87]. Repolarization is due, in part, to both voltage-dependent and Ca2+-activated
K+ channels [88]. These channels generate a hyperpolarizing outward K+ current, which
inactivates voltage dependent L-type Ca2+ channels [88]. Finally, the slow pacemaking phase
generates the rhythmic oscillations in the membrane potential and depolarizes the membrane to
activate L-type Ca2+ channels, supposedley through cationic influx conducted by a non-selective
sodium channel [81, 89]. Overall, processes that alter the expression and activity of ion channels,
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such as hormones, can effect the Vm and/or the shape and length of the action potentials and
subsequently myometrial contractions [90]. This thesis specifically investigates the effect of
hormonal regulation on the expression and activity of a non-selective sodium channel in human
MSMCs and how this may modulate myometrial excitability.

1.3 Sodium Conducting Channels in the Myometrium
1.3.1 Voltage-gated Sodium Channels in the Myometrium
In MSMCs, Na+ influx contributes to myometrial cell excitability [77, 91-93]; however,
the channels responsible for Na+ conductance are not completely understood. In other cell types,
such as neurons [94], voltage-gated Na+ channels are responsible for initiating and propagating
action potentials. At the Vm, these channels are predominantly closed, but upon sufficient
membrane depolarization these channels open, allowing Na+ influx to drive further
depolarization. These voltage-gated Na+ channels can be blocked by the inhibitor tetrodotoxin
(TTX), which is commonly used to study their activity (Fig 1.3). Multiple laboratories have
detected TTX-sensitive voltage-gated Na+ channel currents in MSMCs, but the specific role of
these currents in these cells is still unclear [91]. In neurons, these channels produce action
potentials that typically last only milliseconds (fast activation and inactivation). In contrast,
MSMC action potentials can last hundreds of milliseconds and are more consistent with Ca2+based action potentials, as described earlier. Since it seems unlikely that voltage-gated Na+
channels would initiate and propagate action potentials in MSMCS, studies have attempted to
determine the function of these channels in MSMCs.
There have been many contrasting views on the identification and role of voltage-gated
Na+ channels in MSMCs. On one side, Amedee et al. demonstrated that the Na+ channels in
intact myometrial strips and isolated myometrial cells in short primary culture were TTX11

insensitive [95]. Cytosolic Ca2+ concentration and uterine contractile activity did not change in
rat myometrial strips after adding TTX [96], and TTX did not dampen the propagation of
electrical activity [96, 97]. These functional studies, primarily in rat myometrial cells, suggested
that TTX-sensitive voltage-gated Na+ channels did not contribute to action potentials in MSMCs.
In contrast, Ohya et al. performed whole-cell voltage-clamp experiments on freshly isolated
single rat MSMCs and found TTX-sensitive fast Na+ currents [98]. Additionally, Yoshino et al.
identified inward current that included both Na+ and Ca2+ currents (INa and ICa) in freshly
disassociated MSMCs from non-pregnant, pregnant and post-partum rat uteri [99]. The INa was
voltage dependent, eliminated with either Na+-free medium or 1 μM TTX and larger in MSMCs
from pregnant rats than MSMCs from non-pregnant and postpartum rats [99]. Finally, certain
gene candidates have been proposed for individual Na+ voltage-gated channels; however, no
experiments have been reported on whether any of these genes are responsible for currents in
myometrial cells (Figure 1.3) [77, 100-102]. Overall, this data suggests that voltage-gated Na+
channels may play a role in electrical activity in MSMCs during pregnancy, but better tools are
needed to elucidate this role.

1.3.2 Transient Receptor Potential Cation Channels in the Myometrium
Another Na+-conducting pathway in the MSMCs are transient receptor potential
canonical channels (TRPCs) including TRPC1, TRPC3, and TRPC6. The TRPC channels are
calcium-permeable channels [103-107], which function as a component of the store-operated
calcium entry (SOCE) channels to contribute to electromechanical coupling in the myometrium
(Figure 1.3) [108, 109]. Specifically, depletion of the Ca2+ stores in the sarcoplasmic reticulum
activates, oligomerizes and translocates stromal interaction molecule 1 (STIM1) to the
sarcoplasmic reticulum-plasma membrane junctional regions [110, 111].
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Figure 1.3: Proposed Sodium Entry Pathways in MSMCs
Voltage-gated Na+ channels conduct Na+ and are blocked by TTX. Candidate genes have been
proposed for these channels but their role in Na+ entry and myometrial excitability are still
unknown. TRPC channels primarily conduct Ca2+ but can also conduct Na+. These channels are
stimulated by thapsigargin, IL-1β secretion and mechanical stretch but blocked by Gd3+, 2-ABP,
GsMTx-4 and Pyr3. TRPC, STIM1 and Orai1channels comprise a complex that increases influx
of Ca2+ into the cytoplasm and SR after depletion of the SR-Ca2+ stores. NALCN conducts
primarily Na+ but can also conduct Ca2+ and Cs+. In C. elegans, NALCN is transported to the
plasma membrane with the help of the SR-resident protein NLF-1 [112]. At the plasma
membrane, NALCN can interact with SFK and UNC79 through the scaffolding protein, UNC80
and this complex increases NALCN activity as observed in neurons [113]. Finally, NALCN can
be inhibited by either CaSR under normal Ca2+ concentrations, as shown in neurons [114] or
Gd3+. We propose that NLF-1, UNC79, UNC80 and CaSR modulate NALCN similarly in
myometrial cells.
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This causes an increased conductance of Ca2+ through TRPC channels and Orai1, the poreforming unit of a major channel involved in SOCE [110]. Studies have shown that TRPC1 and
STIM1 physically and electrostatically interact at the ezrin/radixin/moesin domain and polybasic
tail of STIM1, respectively [115, 116]. The electrostatic interaction allows for the gating of
TRPC1 [116]. Finally, knock down of endogenous Orai1 decreases SOCE activity even with
TRPC1-STIM1 overexpression [110, 111, 117].
Even though TRPC channels conduct Ca2+, they can also conduct Na+ [103-107]. TRPC
channels are sensitive to multiple signals, notably mechanical stretch and IL-1β secretion [104],
which can stimulate uterine contraction at term (Figure 1.3). Thus, TRPC channel expression and
activity may increase at the end of pregnancy to promote uterine contraction [104, 118, 119].
Also, thapsigargin, through activation of TRPC channel activity, induces a rise in intracellular
Ca2+ [120] (Figure 1.3). TRPCs are inhibited by gadolinium (Gd3+), 2-Aminoethoxydiphenyl
borate (2-ABP), Grammastola spatulata mechanotoxin #4 (GsMTx4) and pyrazole compound
(Pyr3), this inhibition may affect uterine contractility (Figure 1.3) [110, 121, 122]. For example,
in the presence of 2-ABP, the stretch-induced spontaneous uterine contraction caused by TRPCs
were suppressed, suggesting a possible involvement of TRPC channels in the regulation of
contractions in pregnant myometrium [123]. Overall, these studies shed light on complexes that
contribute to Na+ entry in human MSMCs.

1.4 Na+ Leak Channel, Non-Selective (NALCN)
1.4.1 NALCN Channel and its Complex
In many excitable cells, Na+ influx contributes to the maintenance of Vm and initiation of
action potentials [76]. In neurons, TTX-sensitive voltage gated channels are known to contribute
to the action potential [94, 124], so early studies investigated if these channels functioned
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similarly in MSMCs. Electrophysiological studies performed in rat myometrium found that
substituting Na+ with either Tris or dimethyldiethanol ammonium chloride prevented action
potential generation, whereas blocking Na+ channels with TTX had no effect [91]. Since the data
suggested that the Na+ channels contributing to excitability were neither voltage-gated nor TTXsensitive Na+ channels, other channels need to be considered. One such channel is the sodium
leak channel, non-selective (NALCN).
NALCN, originally called Vgcn11, was cloned from the rat in 1999 and showed
sequence and size similarity to both voltage-gated Ca2+ and Na+ channels (Cav and Nav) [125].
Homologs of this channel have been identified and characterized in both vertebrates and
invertebrates [126]. NALCN, like Nav and Cav, has four homologous repeats (domains I-IV) of
six transmembrane (TM) spanning segments (S1-S6) and is part of the 4x6TM family [125, 127].
Lee et al. and Lu et al. determined that NALCN differs from other channels in the 4X6TM
family in three major ways [125, 127]. One, NALCN contains fewer positively charged amino
acids in the S4 segment making it voltage-insensitive [125, 127]. Two, ion selectivity is formed
by the four S5-S6 pore loops. NALCN has an EEKE motif, a mixture of Cav and Nav motifs,
which creates a non-selective and constitutively active pore that conducts Na+, K+ Cs+, and Ca2+
(Figure 1.3) [125, 127], but primarily conducts Na+. Third, the NALCN current was found to be
resistant to TTX, but sensitive to gadolinium (Gd3+) (Figure 1.3) [125, 127].
In many cell types, several proteins interact with and/or modulate NALCN: NCA
Localization Factor-1 (NLF-1), UNC-80, UNC79, SRC Family Kinase (SFK), and the Ca2+
Sensing Regulator (CaSR) (Figure 1.3). NLF-1, first identified in C. elegans, is located in the
endoplasmic reticulum and promotes membrane localization of all the NCA channels, NALCN
homolog [112]. NLF-1 also plays an important role in the superchiasmatic nucleus in regulating
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the day/night trafficking of NALCN to the plasma membrane of the pacemaker neuron in D.
melanogaster [128]. The other ancillary subunits of the NALCN complex interact with NALCN
at the plasma membrane. In early studies investigating UNC80 and UNC79, Yeh et al. saw that
mutants of unc-79 and unc-80, showed fainter locomotion and decreased Ca2+ transients at
synapses, similar to the phenotypes of mutant nca(lf), in C. elegans [129]. In D. melanogaster,
Lear et al. observed that unc-79 and unc-80 mutants displayed defects in circadian motor
rhythmicity identical to the na mutants, NALCN homolog, and the three proteins co-localized
within the pacemaker neurons [130]. In mice, NALCN, UNC-80 and UNC79 form a complex in
mouse neurons and UNC80 contributes to the stabilization of NALCN at the cell membrane
[113]. This allows UNC80 to function as a scaffold for UNC79 and SFK binding, leading to
activation of NALCN [113]. Both UNC79 and UNC80 have been identified in human MSMCs
but their roles still need to be investigated [92]. Conversely, the Ca2+ sensing receptor (CaSR),
also localized at the cell membrane, negatively modulates NALCN current in neurons [114, 131,
132]. In the presence of normal extracellular Ca2+ levels, CaSR activates a G-protein signaling
cascade to decrease NALCN current in neurons [114]. Overall, further investigation is needed to
identify the ancillary subunits and their role in the modulation of NALCN in human MSMCs.

1.4.2 Human Mutations of NALCN in Neuronal and Respiratory Function
Since 2013, several mutations of NALCN have been identified in children with
neurological deficits and respiratory problems. The nine homozygous NALCN mutations found
result in infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) with
or without respiratory distress [133-138]. Five of these mutations resulted in a truncated protein
by creating premature stop codons in many different locations of the NALCN protein including:
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1) between II and III linker, 2) within the S4 II or S4 IV, 3) linker between S5 and S6 of domain
II, and 4) N-terminus region [133-137]. The other four mutations were missense and led to
milder forms of IHPRF [134, 136]. Bouasse et al found that one such NALCN variant, W1287L,
lead to loss of NALCN current in neurons and supported the prediction that these recessive
mutations in NALCN would cause loss of function [139].
Additionally, many heterozygous, dominant, de novo NALCN mutations have been
discovered in children having congenital contractures of the limbs and face, hypotonia, and
global development delay (CLIFAHDD) [140-144]. Many of these mutations alter amino acid
residues in or near the S5 and S6 pore-forming regions [140-144]. First, Chong et al discovered
that NALCN mutants decreased the expression of NALCN wild type protein when co-transfected
in HEK293 cells, suggesting a dominant-negative effect [140]. Second, Lozic et al discovered
another de novo missense mutation that caused CLIFAHDD but presented with additional
phenotypes [143], which included respiratory distress, reversed sleep-wake cycle and high
sensitivity to anesthetics. All these phenotypes observed in NALCN in mice were found in its
homolog mutants: na (D. melanogaster) and nca (C. elegans) [127, 128, 143, 145-147]. Finally,
patch clamp studies in HEK293 cells transfected with the dominant NALCN mutants revealed an
increased Na+ background current and inactivation [139]. Both characteristics led to a gain-offunction effect, which they suggested arose from a functional alteration instead of a change in
trafficking, since the NALCN mutations actually decreased the number of NALCN on the
plasma membrane [139]. Overall, these human mutations demonstrate the crucial role of
NALCN in normal neurologic function and development.
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1.4.3 The Role of NALCN in Regulating Resting Membrane Potential
Many excitable cells including MSMCs maintain the Vm in a range from -50 to -80 mV.
Although Vm is primarily due to the efflux of K+ ions, the Vm is more depolarized than the K+
equilibrium potential suggesting conductance of other ions. Due to its voltage-insensitivity and
constitutively active pore, NALCN functions at and contributes to regulating the Vm in neurons
of vertebrates and invertebrate organisms [127, 128, 148]. Studies by Lu et al. showed the Vm in
the hippocampal neurons of NALCN knockout mice were more hyperpolarized than the
membrane potential of the wild type controls. This suggested that NALCN provided the
background sodium inward leak current that balanced the outward K+ current to regulate and
maintain the Vm [127]. Additionally, the lack of Na+ leak current reduced the spontaneous firing
rate and required more depolarizing input to achieve similar firing rates as wild type neurons
[127]. Flourakis et al. created forebrain-specific NALCN knockout mice and determined that
central clock neurons that lacked NALCN in the superchiasmatic nucleus (SCN) were similarly
hyperpolarized and silent in firing [128]. Together, these studies identified NALCN as a major
contributor of Vm, in neurons of vertebrates and invertebrate organisms. These studies were
critical as they laid the foundation to investigate if NALCN could also contribute to the Vm of
MSMCs.

1.4.4 The Role of NALCN in Human and Mouse MSMCs
It has been proposed that an important contributor to both the Vm and action potential, is
a non-selective cationic leak current that is constitutively active and voltage-insensitive, but such
a channel had not been identified [125]. In neurons and gastrointestinal cells, NALCN was
characterized as the Gd3+-sensitive Na+-dependent non-selective leak channel that contributed to
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the Vm and the pacemaking phase in action potentials, respectively [127, 149]. Myoshi et al.
measured a Na+-dependent, lanthanum and Gd3+-sensitive leak current in rat MSMCs and
hypothesized that this current contributed to uterine excitability [150]. Inhibiting this leak current
with magnesium, a known cation channel inhibitor, decreased the action potential frequency
[150], but these authors did not identify the channel responsible for the current. Thus, our
laboratory investigated: 1) whether the myometrial leak current described by Myoshi et al. could
be carried by NALCN and 2) the roles of NALCN in human and mouse myometrial physiology.
We showed that human MSMCs express NALCN at both the mRNA and protein level
and possess an ohmic Na+-dependent leak current that was attenuated by Gd3+ or replacement of
Na+ with NMDG, in whole cell patch recordings [92]. Additionally, NALCN was proposed to
contribute to this leak current because shRNA-mediated knockdown of NALCN expression
decreased the leak current [92]. Given these results, our group hypothesized that NALCN
activity is an underlying contributor to myometrial excitability and successful parturition. Reinl
et al. investigated this hypothesis in a mouse model [151]. Our laboratory observed that mice
lacking NALCN in smooth muscle had dysfunctional firing patterns in the uterus, with shorter
burst duration and fewer spikes per burst compared to wild type mice. These changes resulted in
abnormal labor, including prolonged, delayed, and dysfunctional labor [151]. This work revealed
that NALCN contributes to myometrial leak currents and is important for parturition,
establishing the foundation for the work described in this thesis.
Given the importance of ion channels such as NALCN in MSMC excitability, it is not
surprising that expression of many of these channels is regulated by E2 and P4 [85, 152-154]. In
our mouse pregnancy study, we observed that NALCN mRNA and protein expression decreases
mid-pregnancy and increases at term and labor [92], while serum levels of P4 peak during mid19

pregnancy in mice. On the other hand, Soloff et al. reported microarray data indicating that
NALCN was upregulated by P4 and downregulated by E2 in human MSMCs [152]. Although
these data suggest that E2 and P4 regulate NALCN expression, this idea has not been directly
tested. Thus, in my thesis, I investigated the mechanisms by which NALCN is regulated by P4
and E2. A better understanding of the interplay between hormones and ion channels in the uterus
will allow us to design targeted therapies to treat uterine pathophysiology of pregnancy.

1.4.5 The Role of Na+-activated K+ Channel (SLO2.1) in Myometrial Activity
Na+ influx, possibly through NALCN, may contribute to the maintenance of Vm in
MSMCs possibly by activating specific K+ channels. We recently identified a Na+-activated K+
channel (SLO2.1) that may contribute to the Vm of MSMCs and counteract Na+ influx in human
MSMCs [155].
In many excitable cells, including neurons and cardiac cells, a high conducting K+ current
that was activated by Na+, but not activated by Ca2+, Li+, or choline was identified [156-162].
Additionally, the activation of this channel contributed to maintaining Vm in mouse neurons
[163-165]. Further work identified that members of the Slo gene family, slo2.1 and slo2.2 encode
for KNa channels, SLO2.1 and SLO2.2, respectively [158, 160]. The slo2 genes are related to the
Slo1 family, which encodes the large-conductance Ca2+-activated K+ channels and Slo3 family,
which encodes a pH-sensitive K+ channel [158, 166, 167]. Specifically, SLO2.1 currents are
rapidly inactivating and less voltage dependent, while SLO2.2 currents are slow inactivating and
voltage sensitive [160, 168]. Finally, initial expression studies observed that slo2.1 mRNA was
widely distributed in the uterus, brain, testis, lung, heart, and liver, while slo2.2 was
predominantly in the brain [155, 158].
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The expression of SLO2.1 in the uterus is a candidate for the Na+-activated K+ channel in
the MSMCs and may suggest a functional partner for NALCN. To determine if SLO2.1
functioned similarly in MSMCs as described in other excitable cell types, Ferreira et al.
performed whole-cell and inside-out macro patch clamp experiments in MSMCs and identified a
non-inactivating K+ current that was resistant to TEA and activated by Na+ [155]. This current
had high conductance at both +80 mV and -60 mV (Vm of MSMCs), consistent with a KNa
current that could contribute to the Vm. Additionally, mRNA and protein analysis indicated that
this current was attributed to SLO2.1 but not SLO2.2 in human MSMCs [155]. When siRNA
targeted against SLO2.1 was introduced into human MSMCs, this KNa current disappeared.
Thus, the investigators concluded KNa current was conducted by SLO2.1. These studies point to
the broad importance of SLO2.1 as a modulator of Vm and excitability. This thesis investigates if
Na+ entry through NALCN activates SLO2.1 and if their association regulates myometrial Vm
and excitability.

1.5 The Regulation and Role of NALCN in Human
Myometrial Cells
In my thesis work, I investigated the hormonal regulation of NALCN and its contribution
to myometrial excitability in human MSMCs. First, it was established that P4, the pro-quiescent
hormone, upregulates the expression of NALCN by acting through progesterone response
elements in the NALCN promoter. On the other hand, E2, the pro-contractile hormone,
downregulates this channel in humans MSMCs, independent of binding to the estrogen response
element within the NALCN promoter. These effects on NALCN expression translated
functionally as P4 significantly enhanced, and E2 significantly inhibited a NALCN-dependent
leak current in human MSMCs. These findings also show that NALCN contributes to the Vm and
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excitability of human MSMCs. Specifically, a Gd3+-sensitive Na+-conducting leak channel
activates the SLO2.1 current and NALCN and SLO2.1 are in proximity. The NALCN-dependent
leak current modulates Vm and responses to intracellular Ca2+ by activating SLO2.1 currents.
This work has identified novel hormonal regulators of NALCN and recognized NALCN as an
important player in contributing to the Vm in order to modulate myometrial excitability.
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2.1 Introduction
The strength and frequency of myometrial contractions are regulated to support the
multiple functions of the uterus including expulsion of the endometrial lining during
menstruation, sperm transport during fertilization, embryo implantation, fetal growth, and
32

parturition [1]. During pregnancy, the uterus remains quiescent to support fetal development, but
at term, it produces synchronous and forceful contractions to deliver the fetus [2]. Two hormones
essential for this transition are progesterone (P4) and estrogen (E2).
P4 represses expression of several genes that increase responsiveness to uterotonic
agonists and enhance myometrial contractility during the majority of pregnancy. P4 functions
through two major progesterone receptor (PR) isoforms, PRA and PRB. PRB, the full-length
canonical form, predominates throughout pregnancy and mediates myometrial quiescence [3].
For example, after binding to P4, nuclear PRB represses transcription of genes encoding
interleukin-8, cyclooxygenase 2, oxytocin receptor, connexin-43, and nuclear factor kappa B
(NF-κB) subunit [4-6], all of which are associated with inflammation and contractility. In
addition to directly binding to the progesterone response elements (PRE) within a gene, the P4PR complex can tether to pro-inflammatory transcription factors (e.g., NF-κB or AP-1) and
recruit co-repressors, such as p54, to inhibit transcription [7-11]. P4-PR repression of proinflammatory genes also occurs by two other mechanisms. First, P4-PR can decrease the
recruitment of RNA polymerase II and NF-κB p65 to COX-2 and IL-8 promoters and thus
decrease their expression [12]. Second, P4-PR increases the expression of the zinc finger E-box
binding homeobox protein, ZEB1, which inhibits expression of contractile genes and the miR200 family during pregnancy and thus delay the myometrial transitions to a contractile
phenotype [8, 13, 14].
As pregnancy progresses to term and into labor, P4 function is decreased in human
myometrium, leading to a pro-contractile state [15, 16]. One mechanism by which this P4
functional withdrawal may occur is that expression of PRA, which lacks 164 amino acids
including the AF3 activation domain in the N-terminus, increases at the end of pregnancy. This
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increased PRA expression leads to an increase in the PRA:PRB ratio, resulting in decreased
P4/PRB-mediated gene expression. Other mechanisms underlying this P4 functional withdrawal
include changes in the levels of PR-associated co-regulators [17], increased expression of
specific endogenous PR antagonists [18], and increased expression of the P4 metabolizing
enzyme, 20α HSD [14]. Whereas P4 promotes quiescence, E2 promotes contraction by binding
to the estrogen receptor α (ERα) in the myometrium [4, 11, 14]. E2 serum levels also increase as
the pregnancy moves towards labor. The E2-ERα complex binds to estrogen response elements
(EREs) in genes encoding contractile-associated proteins and inflammatory genes, leading to
their upregulation and promoting labor [16, 19, 20]. In addition to the genomics effects, E2
exerts non-genomic effects through ERα activation of the extracellularly regulated
kinase/mitogen-activated protein kinase pathway [21].
Other proteins that regulate the transition from uterine quiescence to contractility are the
multiple ion channels that are expressed in myometrial smooth muscle cells (MSMCs). Together,
these ion channels regulate MSMC membrane potential and excitability by controlling sodium
ion (Na+) influx, potassium ion (K+) efflux, and calcium ion (Ca2+) influx [22-25]. At a resting
state, the myometrial membrane potential is approximately -60 mV. As positive charge ‘leaks’
into the cell, the membrane becomes less polarized until it reaches a threshold potential at which
L-Type Ca2+ channels are activated, causing an influx of Ca2+. This Ca2+ influx both depolarizes
the membrane and leads to activation of myosin and contraction [26, 27]. Membrane potential is
restored by efflux of K+ through K+ channels [28-31]. The activities of the many ion channels
controlling these changes in membrane potential are regulated to promote uterine quiescence
throughout pregnancy and contractility at term [29].
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Voltage-independent, non-selective cationic leak currents can be important contributors
to cell excitability, and RNA sequencing data has detected the expression of a Na+ leak channel,
non-selective (NALCN) in

human myometrial tissue [29]. Recently, our lab showed that

NALCN contributes to at least 50% of the Na+ leak current in MSMCs isolated from nonlaboring women at term [32], and that mice lacking NALCN in smooth muscle had dysfunctional
labor [33]. Collectively, these findings suggest that NALCN contributes to myometrial
exciability and reproductive outcomes. Given the importance of ion channels such as NALCN in
MSMC excitability, it is not surprising that expression of many of these channels is regulated by
E2 and P4 [22, 34-36]. Specifically, Soloff et al. reported microarray data indicating that
NALCN was upregulated five-fold in human MSMCs after exposure to P4 [34]. Although these
data suggest that E2 and P4 regulate NALCN expression, this idea has not been directly tested.
Here, we tested the hypothesis that E2 and P4 regulate NALCN expression and current activity
in human MSMCs.

2.2 Materials and Methods
2.2.1 Cell Culture
All cell lines were maintained in 95% air, 5% CO2 at 37 °C and were confirmed
mycoplasma-negative with MycoAlert Mycoplasma Detection Kit (Lonza) before experiments.
Generation and characterization of the HM6ERMS2 cells was previously described [34,
37]. HM6ERMS2 cells were maintained in phenol red-free Dulbecco’s modified Eagle
medium/Ham’s F12 (1:1) (DMEM) (Ref. 11039, Gibco, Grand Island, NY, USA) supplemented
with 10% fetal bovine serum (FBS) (Ref. 26140079, Gibco) and 25 μg/mL gentamicin (Sigma,
St. Louis, MO). During E2 and P4 treatments, the cells were maintained in DMEM
supplemented with 0.5% bovine serum albumin (Sigma) and 25 μg/mL gentamicin.
35

Generation and characterization of the human telomerase reverse transcriptaseimmortalized-human myometrial (hTERT-HM) cells stably expressing FLAG-tag PRA or PRB
(hTERT-HM FLAG-tag PR) or lentiviral mock vector was previously described [11, 38]. The
hTERT-HM mock, FLAG-tag PRA, and FLAG-tag PRB cells were maintained in phenol redfree DMEM supplemented with 10% FBS and 5 µg/ml blasticidin (Gibco). Twenty-four hours
before and during hormone treatments, cells were switched to media with 10% charcoal-stripped
FBS (Ref. 12676029, Gibco).
The Michigan Cancer Foundation 7 (MCF-7) cells, a breast cancer cell line, were
maintained in ATCC-formulated Eagle’s Minimum Essential Medium (Catalog No, 30-2003,
ATCC, Manassas, VA) supplemented with 10% FBS. For transfection and hormonal treatments,
MCF-7 cells were maintained in their media supplemented with 10% charcoal-stripped FBS.

2.2.2 Hormone Treatment
Progesterone (P4), 17β-estradiol (E2), RU486 (PR antagonist), and ICI 182,780 (ICI, ER
antagonist) were of the purest quality available from Sigma. For HM6ERMS2 cells, vehicle
treatment was as follows: 0.05% EtOH on all three days. E2 treatment was as follows: 20 nM E2
on day 1, and 2 nM E2 on days 2 and 3. ICI 182,780 was administered every day at 1 µM along
with the estradiol concentrations listed above. E2/P4 treatment was as follows: 20 nM E2 on day
1, 2 nM E2 on day 2, and 2 nM E2 and 100 nM P4 on day 3. RU486 was administered at 1 µM
on Day 3 along with the E2/P4 treatments. P4 treatment was as follows: 0.05% EtOH for days 1
and 2 and 100 nM P4 on day 3. For hTERT FLAG-tag PR cells, progesterone treatment was as
follows: 100 nM P4 on day 1. For both cell types, all assays were performed on the day after the
last treatment day.
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2.2.3 RNA Isolation, cDNA Synthesis, and Quantitative Real-time PCR
Total RNA was isolated from HM6ERMS2 and hTERT-HM FLAG-tag PR cells by using
the RNeasy/QIAshredder Mini Kit (Qiagen, Germantown, MD) and treated with RNase-Free
DNase (Qiagen) according to the manufacturer’s instructions. RNA quality was confirmed by
two methods: 1) electropherogram bioanalyzer of the 28S to 18S rRNA ratio, and 2) 260/280 nm
and 260/230 nm absorbance ratios above 1.8 and 2.0, respectively. RNA (200 ng) was reverse
transcribed to generate cDNA by using the iScript Reverse Transcription Supermix for
quantitative real-time PCR (Bio-Rad, Hercules, CA, USA). cDNA was stored at -20°C until
quantitative real-time PCR was performed. Gene targets were amplified with iQ SYBR Green
Supermix (BioRad) and quantified with the CFX96 BioRad Real-Time PCR Detection System.
Temperature cycles were as follows: 95 °C for 3 min, 40 cycles of (95 °C for 10 sec, 60 °C for
30 sec), and a 0.5 °C increment melt curve from 65 °C to 95 °C. Primer efficiencies were ≥80%
with human brain cDNA and hTERT-HM lentiviral mock vector. Samples were run in parallel
with standard curves to generate accurate copy numbers from threshold cycles. Copy numbers of
the measured genes were normalized to the geometric mean of the copy numbers of the reference
genes topoisomerase 1 (TOP1), succinate dehydrogenase complex subunit A (SDHA), and
smooth muscle alpha actin 2 (ACTA2). These genes are stably expressed in the myometrium
[39]. The primer sequences are listed in Table 2.1.
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Table 2.1 Primer sets used for quantitative RT-PCR
Primer name
mRNA Primers

Sequence

hNALCN_F

ACTGACTTTGGTCCTGATGA

hNALCN_R

ACTGAAGTGGAGGATAGTGC

hTOP1_F

CCAGACGGAAGCTCGGAAAC

hTOP1_R

GTCCAGGAGGCTCTATCTTGAA

hSDHA_F

CAAACAGGAACCCGAGGTTTT

hSDHA_R

CAGCTTGGTAACACATGCTGTAT

hACTA2_F

GCCTTGGTGTGTGACAATGG

hACTA2_R

AAAACAGCCCTGGGAGCAT

hPRB_F

TCCAGTCCTCGGACAGAAGT

hPRB_R

GGAACTGTGGCTGTCGTTTG

hFKBP5_F

ATGCCATTTACTGTGCAAACCAG

hFKBP5_R

AAGAGAGTTGCATTCGAGGAA

Cloning/Restriction Primers

Cloning Sequence

hNALCN_F

GCAAATGGGAAGTATATGCC

hNALCN_R

GCTCAGAGCTGTCATGGTG

hNALCN_Nhe1_F

CTAGCTAGCTAGGCAAATGGGAAGTATATGCC

hNALCN_Xho1_R

CCGCTCGAGCGGGCTCAGAGCTGTCATGGT
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2.2.4 Whole-cell Lysate Preparations and Western Blotting
Cultured HM6ERMS2 cells were transferred into RIPA Buffer (150 mM NaCl, 50 mM
Tris, 1% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS], pH
8.0) (Sigma) containing cOmplete Mini EDTA-free Protease Inhibitor Cocktail and PhosStop
EASYpack (Roche, Indianapolis, IN) and homogenized with the Bullet Blender 24 (Next
Advance Inc., Troy, NY) at 4 °C. Lysates were centrifuged at 14,000 x g for 15 min at 4°C.
Supernatants were stored at -80 °C. Protein concentrations of whole-cell lysates were measured
by using a bicinchoninic acid protein assay kit (Pierce, Rockford, IL, USA). Lysate samples
containing equal amounts of protein were mixed with 6X SDS gel loading buffer (375 mM TrisHCl, 6% SDS, 48% glycerol, 9% β-mercaptoethanol, and 0.03% bromophenol blue, pH 6.8), and
incubated for 5 min at 100°C. Denatured samples were electrophoresed on precast 4% to 15%
Tris-Glycine polyacrylamide gels, transferred to nitrocellulose membrane, and blocked in 5%
non-fat dried milk (Bio-Rad, Hercules, CA) in 0.075% Tween-Phosphate buffered saline (PBST) for 1 h at room temperature. The membranes were incubated overnight at 4 ºC with primary
antibodies, then incubated for 1 h at room temperature with appropriate secondary antibodies in
3% milk in 0.075% PBS-T. Antibodies are listed in Table 2.2. Signal was detected with
Supersignal West Femto (Thermo Fisher Scientific, Waltham, MA, USA) and viewed with a
ChemiDoc MP Imaging System (BioRad). For analysis, a flat line was drawn across the base of
the intensity peak for each band to subtract background, and the area under the curve was
quantified. NALCN expression was normalized to Histone H3 expression by densitometry with
ImageJ software.
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Table 2.2 Primary and Secondary Antibodies for Western Blot
Name of Antibody Manufacturer, Catalog Number, RRID

Species raised in; Dilution
monoclonal (mAb) Used
or polyclonal (pAb)
NALCN [S187-7] StressMarq, SMC-417, AB_2701253
Mouse, mAb
1:1000
PR (H-190)
Santa Cruz Biotechnology, sc-7208, AB_2164331 Rabbit, pAb
1:1000
Erα (HC-20)
Santa Cruz Biotechnology, sc-543, AB_631471 Rabbit, pAb
1:1000
Histone H3
Abcam, ab1791, AB_302613
Rabbit, pAb
1:5000
β-Actin
Millipore Sigma, A1978, AB_476692
Mouse, mAb
1:5000
GAPDH
Millipore, MAB374, AB_2107445
Mouse, mAb
1:2000
Anti-Rabbit IgG Jackson ImmunoResearch, 111-035-144,
(H+L) HRP-linked AB_2307391
Goat, pAb
1:2000
Anti-Mouse IgG Jackson ImmunoResearch, 115-035-003,
(H+L) HRP-linked AB_10015289
Goat, pAb
1:2000
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2.2.5 Immunocytochemistry
HM6ERMS2 cells were fixed in 4% paraformaldehyde in PBS for 20 min at room
temperature, briefly washed with PBS, and then permeabilized with 0.1% NP40 in PBS for 5
min. Cells were then washed with PBS and 10 mM glycine and incubated in blocking buffer
(PBS with 5% Normal Goat Serum [NGS]) for 1 h, incubated with an NALCN-specific antibody
(1:500, S187-7, StressMarq, Victoria, British Columbia) diluted in antibody buffer (PBS with
1% NGS and 0.1% Tween-20) overnight, and washed 3 times for ~30 min in wash buffer (250
mM NaCl, 25 mM Tris HCl, 0.1% Tween-20, pH 7.5). Cells were incubated with goat antimouse IgG (H+L) Alexa Fluor Plus 488 (1:2000, Invitrogen, Carlsbad, CA) diluted in antibody
buffer for 1 h, washed, and incubated with 1 µg/mL 4’,6-diamidino-2-phenylindole, and then
mounted in Vectashield Antifade Mounting Medium (Vector Laboratories, Burlingame, CA).
Cells were imaged with a 63x oil objective on a Leica DMI4000 B microscope. To assess the
specificity of NALCN immunostaining, cells were stained with primary antibody only,
secondary antibody only, or in the absence of permeabilization. All controls were processed with
the same parameters employed for the NALCN antibody.

2.2.6 Whole-cell Electrophysiology
Glass pipettes were pulled and polished to 2-6 MΩ and filled with a pipette solution
containing 125 mM Cs-Aspartate, 20 mM tetraethylammonium (TEA)-Cl, 5 mM Mg-ATP, 5
mM EGTA, 100 nM free Ca2+ (calculated with Maxchelator software [Stanford University]), and
10 mM HEPES, pH 7.2 [32]. In the intracellular solution, K+ was replaced with Cs+.
Extracellular bath solution contained 125 mM NaCl or N-methyl-d-glucamine (NMDG), 20 mM
TEA-Cl, 0.1 mM MgCl2, 5 mM HEPES, 11 mM glucose, 1 μM CaCl2, and 5 μM nifedipine, pH
7.4. TEA-Cl and nifedipine were added to the bath solution to isolate the leak current by
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blocking voltage-gated K+ and Ca2+ channels, respectively. Additionally, 10 μM gadolinium
(Gd3+), a concentration known to inhibit NALCN current [40], 500 nM Grammastola spatula
mechanotoxin #4 (GsMTx4; blocks TRPC1 and TRPC6), and 1 μM pyrazole compound (Pyr3;
blocks TRPC3) were added to the bath solution to determine NALCN’s contribution to the leak
currents [40-42]. Currents in HM6ERMS2 cells were recorded at a sampling rate of 10 kHz and
filtered at 1 kHz by using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA,
USA). Cells were held at -60 mV and currents were elicited by stepping from −55 mV (50 ms) to
+40 mV for 100 ms (to inactivate voltage-gated Ca2+ channels followed by 20 mV steps (500
ms) from −100 mV to +20 mV using the pClamp 10 software (Molecular Devices). Currents
were normalized to cell capacitance, and the mean and standard error of the mean of the current
density were calculated for each group of samples. In all whole-cell patch-clamp recordings, the
investigator was blinded to the cell treatments.

2.2.7 Cloning of NALCN promoter region and mutagenesis of PRE and ERE sites
The human NALCN promoter region, from 2479 bp upstream to 183 bp downstream of
the transcription start site, was amplified from genomic DNA in hTERT-HM FLAG-tag PR cells
with Phusion High Fidelity DNA Polymerase (NEB, Ipswich, MA). Primers are listed in Table
2.1. The amplified insert was re-amplified with primers that contained Nhe1 and Xho1 sites
(Table 2.1), digested with Nhe1 and Xho1, and ligated into the pGL3-Basic firefly luciferasereporter vector (Promega, Madison, WI) to create the construct pGL3-Basic-NALCN, which was
confirmed by restriction digests and Sanger Sequencing (Genewiz, South Plainfield, NJ).
Standard procedures were used for plasmid amplification and purification. Genewiz performed
site-directed mutagenesis of putative progesterone response elements and estrogen response
element.
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2.2.8 Transfection and luciferase reporter assay
MCF7 cells were seeded in 96-well plates, and FuGENE HD transfection reagent (Roche
Applied Science) was used to co-transfect cells with a Renilla luciferase-expressing plasmid
(pGL4.74) (Promega) and the pGL3-Basic-NALCN wild-type or mutant constructs. Sixteen
hours post-transfection, cells were treated with either EtOH or 20 nM E2. Twelve hours later,
cells were treated with EtOH, 2 nM E2, or 100 nM P4. Twenty-four hours later, firefly luciferase
and Renilla luciferase activities were assayed by using a Dual-Luciferase assay system
(Promega). Relative luciferase activities were calculated by normalizing firefly luciferase
activity to Renilla luciferase activity within the same samples to correct for transfection
efficiency.

2.2.9 Statistical Analysis
All data are presented as mean ± SEM. Statistical significance was determined by
unpaired t-test (two groups), or one- or two-way ANOVA (three or more groups) correcting for
multiple comparisons by using GraphPad Prism 7 (San Diego, CA, USA), and P < 0.05 was
considered significant. The ‘n’ refers to the number of experiments analyzed from different days
or transfections.

2.3 Results
2.3.1 NALCN Expression is Decreased by Estrogen and Increased by Progesterone
To determine whether the hormones E2, P4, or both regulate NALCN mRNA and protein
expression in human myometrial cells, we used HM6ERMS2 cells, a myometrial cell line
derived from uterine tissue from a woman late in pregnancy [37]. The cell line stably expresses
ERα and expresses PRA and PRB after at least 12 hours of E2 treatment (Figure 2.1A) [34, 37].
We performed hormonal treatments as previously described [15, 16, 43] in HM6ERMS2 cells in
43

four conditions: 1) vehicle-treated, 2) E2-treated, 3) E2/P4-treated, and 4) P4-treated. To confirm
that ERα was functional, we measured mRNA expression of the E2/ERα target PRB [34, 44].
Quantitative RT-PCR showed that PRB mRNA expression was 13-fold higher in cells exposed
to E2 alone and 5.2-fold higher in cells exposed to E2/P4 than in cells exposed to vehicle (Figure
2.1B). Cells exposed to E2/P4 expressed 2.4-fold less PRB mRNA than cells exposed to E2
alone, likely due to down-regulation of PRB transcription by P4 signaling [45-48]. To confirm
that PR was functional, we measured mRNA expression of the PR target, FK506 binding protein
51 (FKBP5) [5, 49]. Cells exposed to E2/P4 expressed 2.5-fold more FKPB5 mRNA than cells
exposed to any of the other treatment conditions (Figure 2.1C). Together, these results confirmed
that ERα and PR were functional in the HM6ERMS2 cells.
Next, we investigated the effects of hormones on NALCN expression in myometrial cells. First,
qPCR revealed that NALCN mRNA expression was 2.3-fold lower in cells exposed to E2 alone
than in cells exposed to vehicle (Figure 2.2A). Conversely, NALCN mRNA expression was 5.6fold higher in cells exposed to E2/P4 than in cells exposed only to E2. NALCN mRNA was
similar in cells exposed to P4 alone and cells exposed to vehicle (Fig 2.2A). The fact that
NALCN expression was not increased in cells treated with P4 alone (which do not express PR)
supports the idea that P4 requires the presence of PR to regulate NALCN expression.

44

Figure 2.1: ER and PR regulate transcription of PRB and FKBP5
A) Representative immunoblot of ERα, PR-A, and PR-B proteins in HM6ERMS2 whole-cell
lysates. GAPDH served as the loading control. All samples were run on the same gel and
exposed at the same time. B) Quantification of qRT-PCR of PRB mRNA in HM6ERMS2 treated
with vehicle (N=5), E2 (N=5), E2/P4 (N=5), or P4 (N=5). C) Quantification of qRT-PCR of
FKBP5 mRNA in HM6ERMS2 treated with vehicle (N=5), E2 (N=5), E2/P4 (N=5), or P4
(N=5). The geometric means of TOP1, SDHA and ACTA2 were used as standards for
quantification. Data are presented as mean and standard error of the mean. *P<0.05, **P<0.01
by Dunnett’s multiple comparison test one-way ANOVA. MW, molecular mass.
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Figure 2.2: E2 and P4 regulate NALCN mRNA and protein expression
A) Quantification of qRT-PCR of NALCN mRNA in HM6ERMS2 treated with vehicle (N=5),
E2 (N=5), E2/P4 (N=5), P4 (N=5), E2 and ICI 182,780 (ICI) (N=3), or E2/P4 and RU486 (N=3).
The geometric means of TOP1, SDHA, and ACTA2 were used as standards for quantification.
B) Representative Western blot of NALCN in HM6ERMS2 whole-cell lysates. Histone H3
served as the loading control. C) Quantification of NALCN protein in the HM6ERMS2 wholecell lysates; N=5. NALCN signal was normalized to Histone H3. D) Representative
immunofluorescence images of NALCN in HM6ERMS2 cells treated as indicated. (Scale Bar,
50 µm). Data are presented as mean and standard error of the mean. *P<0.05, **P<0.01 by
Dunnett’s multiple comparison test one-way ANOVA. MW, molecular mass.
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To confirm that E2 and P4 regulated NALCN expression via their respective receptors,
we used the ER antagonist ICI 182,780 and the PR antagonist RU486. Cells treated with both E2
and ICI 182,780 had higher NALCN mRNA expression than cells treated with E2 alone,
indicating that E2 represses NALCN expression via acting on ER. Additionally, cells treated
with E2/P4 and RU486 had significantly less NALCN mRNA than cells treated with E2/P4,
indicating that P4 promoted NALCN expression by acting on PR (Fig 2.2A). These results
suggest that E2 decreases, and P4 increases NALCN gene expression.
To determine whether E2 and P4 also regulated NALCN protein expression, we
performed immunoblots detecting NALCN in the hormone-treated HM6ERMS2 cells. A
representative blot (Figure 2.2B) and quantitation of five replicates (Figure 2.2C) showed that
NALCN protein was 2.3-fold lower in cells exposed to E2 than in cells exposed to vehicle.
Conversely, we detected no statistically significant difference in NALCN protein expression in
cells exposed to vehicle, E2/P4, and P4 alone (Figure 2.2B, C). Immunofluorescence
experiments confirmed these findings, as NALCN staining was less evident in cells exposed to
E2 than in cells exposed to vehicle or E2/P4 (Figure 2.2D). Together, these experiments indicate
that E2 (the pro-contractile hormone) reduces NALCN mRNA and protein expression, whereas
P4 (the pro-quiescent hormone) restores NALCN expression in cells in which PR is expressed
(cells exposed to E2/P4).
Cellular responses to P4 differ depending on whether they express more PRA, which
promotes contractility, or PRB, which promotes quiescence [5, 11]. In HM6ERMS2 cells, PRA
and PRB are expressed in similar amounts (Figure 2.1A). Thus, to determine which receptor
promoted NALCN expression, we used a human myometrial cell line (hTERT-HM) stably
expressing FLAG-tag PRA or FLAG-tag PRB [11] (Figure 2.3A).
47

Figure 2.3: NALCN mRNA expression is upregulated by both PRA and PRB
A) Representative Western blot of PRA and PRB in hTERT-HM cells expressing empty vector,
FLAG-tag PRA, and FLAG-tag PRB. β-actin served as a loading control. B) Quantification of
qRT-PCR of NALCN mRNA in hTERT FLAG-tag PR cells as indicated; N=3 for Empty vector,
N=5 for PRA, and N=4 for PRB. The geometric means of TOP1, SDHA, and ACTA2 were used
as standards for quantification. Data are presented as mean and standard error of the mean. **P
<0.01 by unpaired t-test. MW, molecular mass.
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Supplementary Figure 2.1: NALCN mRNA expression is upregulated by both PRA and
PRB.
Quantification of qRT-PCR of NALCN mRNA in hTERT FLAG-tag PR cells as indicated; N=3
for Empty vector, PRA, and PRB. The geometric means of TOP1, SDHA, and ACTA1 were
used as standards for quantification. Data are presented as mean and standard error of the mean.
**P <0.01 by unpaired t-test.
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Whereas P4 had no effect on cells expressing empty vector, P4 treatment increased NALCN
mRNA expression ~2.0 fold in both the FLAG-tag PRA and FLAG- tag PRB cells (Figure 2.3B
and Supp. Figure 2.1). Thus, P4 signaling through both PRA and PRB can promote NALCN
expression.

2.3.2 NALCN Activity is Reduced by E2 and Increased by P4
To determine whether E2- and P4-mediated changes in NALCN expression translated
into changes in Na+ current in MSMCs, we performed whole-cell patch clamping experiments in
treated HM6ERMS2 cells. We first measured Na+ leak current in vehicle-, E2-, and E2/P4treated cells in the absence and presence of the non-specific NALCN blocker gadolinium (Gd3+)
[32, 40]. In cells treated with vehicle, a leak current was identified at all voltages (Figure 2.4A,
B). In vehicle-treated cells, currents at -60 mV, near the resting membrane potential, were
significantly larger in cells in the absence of Gd3+ than in the presence of 10 µM Gd3+ (-2.59 ±
0.53 pA/pF vs. -1.57 ± 0.50 pA/pF) (Table 2.3). This indicated the presence of a Gd3+-sensitive
current with an average pA/pF of -1.01 ± 0.22 (Figure 2.4C), consistent with our previous
observations [32]. At all voltages, the Gd3+-sensitive current was smaller in E2-treated cells than
in vehicle-treated cells and higher in E2/P4-treated cells than in E2-treated cells (Fig 2.4B). In
particular, the Gd3+-sensitive current, measured at -60 mV, was significantly smaller in cells
treated with E2 than in cells treated with vehicle (-0.24 ± 0.08 pA/pF vs. -1.01 ± 0.22 pA/pF)
(Figure 2.4C). Finally, the Gd3+-sensitive current at -60 mV was significantly larger in cells
treated with E2/P4 than in cells treated with E2 (-0.75 ± 0.18 vs. -0.24 ± 0.08 pA/pF) (Figure
2.4C).
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Figure 2.4: NALCN activity is reduced by E2 and increased by P4 in HM6ERMS2 cells
A) Representative traces of leak currents evoked from HM6ERMS2 cells treated with vehicle,
E2, and E2/P4 by using a voltage step protocol with 20 mV increments from -100 mV to +20
mV, before and after treatment with 10 μM Gd3+. Capacitive currents were removed from these
traces. B) Current-voltage relationships of the Gd3+-sensitive current obtained from HM6ERMS2
cells treated with Vehicle (n=6), E2 (n=7), or E2/P4 (n=9). C) Gd3+-sensitive current density
analysis at -60 mV after treatment with Vehicle, E2, or E2/P4. Each symbol represents an
individual cell. D) Control and TRPC inhibitor-resistant current density analysis at -60 mV in
cells treated with Vehicle (n=3), E2 (n=5), or E2/P4 (n=6) in the absence or presence of 500 nM
GsMTx4 and 1 μM Pyr3. Each symbol represents an individual cell. E) NMDG-sensitive current
density analysis at -60 mV after treatment with Vehicle (n=5), E2 (n=7) or E2/P4 (n=7). Data are
presented as mean and standard error of the mean. *P<0.05, **P<0.01 by Dunnett’s multiple
comparison test one-way ANOVA.
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In addition to blocking NALCN, Gd3+ blocks Na+ current through TRPC channels, which are
expressed in human MSMCs [50-53]. To confirm that the Gd3+ sensitive current measured in
HM6ERMS2 cells was carried by NALCN, we repeated our experiments in the presence or
absence of the TRPC1/TRPC6 blocker GsMTx4 and the TRPC3 blocker Pyr3. At -60 mV, the
leak current in all treatment conditions was unaffected by the TRPC blockers (Figure 2.4D,
Table 2.3). Therefore, NALCN current is largely responsible for the Gd3+ sensitive current in
these cells.
Because NALCN is a non-selective channel, we wanted to determine the predominant
cations contributing to the current in HM6ERMS2 cells. Thus, we performed patch-clamp
experiments in which we replaced Na+ in the bath with the channel-impermeable monovalent
cation NMDG. This reduced the conductance to a similar extent as the addition of Gd3+ (Figure
2.4E, Table 2.3). Taken together, these results suggest that NALCN is the predominant Na+conducting channel regulated by E2 and P4 in HM6ERMS2 cells.

2.3.3 P4 regulates NALCN through progesterone response elements in the NALCN
promoter
To further define the mechanisms underlying E2- and P4- mediated regulation of
NALCN expression, we searched the promoter region of the gene that encodes NALCN,
VGCNL1, for estrogen and progesterone response elements (EREs and PREs). The ERE
consensus sequence is GGTCAnnnTGACC and the PRE sequence is GnACAnnnTGTnC (Fig
2.5A).
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Table 2.3 Summary of Leak Current Parameters in HM6ERMS2 cells

Treatment
(n)

Vehicle
E2
E2/P4

Current Density
(pA/pF)
Control
-2.59 ±
0.53 (6)
-0.66 ±
0.28 (7)
-1.65 ±
0.40 (9)

#

#

#

Current Density
Current Density
(pA/pF)
(pA/pF)
500 nM
NMDG
3+
Control
GsMTx4
& Control
10 μM Gd
Resistant
1 μM Pyr3
-1.57 ± 0.50** -1.73 ± 0.11 -1.80 ± 0.21 -3.14 ± 0.69 -1.42 ±
(6)
(3)
(3)
(5)
0.40* (5)
-0.42 ± 0.20* -0.68 ± 0.21 -0.72 ± 0.21 -1.01 ± 0.27 -0.55 ±
(7)
(5)
(5)
(7)
0.21* (7)
-0.90 ± 0.28** -0.96 ± 0.18 -0.99 ± 0.19 -2.05 ± 0.52 -0.89 ±
(9)
(6)
(6)
(7)
0.17* (7)

Mean Values ± SEM
# Calculated at -60 mV
*P< 0.05 and **P< 0.01 from paired Student's t-test comparing before and after treatment
3+
with Gd -, GsMTx4/Pyr3-, or NMDG-containing solution.
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We used the AliBaba 2.1 TRANSFAC program [54] to search the region between the VGCNL1
transcription start site and approximately 2.5 kb upstream and found two consensus PREs located
1023 bp (PRE1) and 2447 bp (PRE2) upstream of the VGCNL1 transcription start site.
Additionally, we identified a sequence that matched both ERE and PRE consensus sequences
390 bp (ERE1/PRE3) upstream of the transcription start site (Figure 2.5A). We cloned the ~2.5kb wild-type (WT) VGCNL1 promoter sequence upstream of the firefly luciferase gene in the
pGL3-Basic Luciferase vector (VGNCL1-pGL3BasicLuc) and co-transfected this vector with a
vector encoding Renilla luciferase into the breast cancer cell line MCF-7. MCF-7 cells
constitutively express ERα and express PR after 12 h of E2 treatment [55-57].
In the cells with WT promoter, firefly luciferase activity was 42% lower in MCF-7 cells
exposed to E2 than in cells exposed to vehicle and 40% higher in cells exposed to E2/P4 than in
cells exposed to vehicle (black bars in Figure 2.5C), indicating that the VGCNL1 promoter was
regulated by E2 and P4. To confirm that any low concentration of E2 in the phenol redcontaining media in which MCF-7 cells are normally maintained [58] did not confound our
results, we repeated the experiments in phenol red-free media. We observed similar results in
both types of media (Supp. Figure 2.2).
To test whether the putative PREs and the ERE were required for PR- and ER-mediated
regulation of VGCNL1 promoter activity, we introduced site-specific mutations that are known to
decrease PR and ER binding to their respective response elements (Figure 2.5B) [59-62]. None
of the PRE or ERE point mutations had a significant effect on firefly luciferase activity in cells
treated with E2 (Figure 2.5C).
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Figure 2.5: P4 regulates progesterone response elements in the NALCN promoter
A) Schematic showing the structure of the NALCN promoter sequence, including the putative
PREs and ERE. B) Alignment of the PRE and ERE consensus, wild type, and mutant sequences.
C) Relative firefly luciferase activities (normalized to Renilla luciferase activity in the same
samples) of cells transfected with expression vectors carrying the indicated constructs after
treatment with E2 or E2/P4. Data are shown as mean and standard error of the mean. N=5 for
each treatment group. ***P<0.001 by Dunnett’s multiple comparison test two-way Anova.
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Supplementary Figure 2.2: P4 regulates progesterone response elements in the NALCN
promoter.
Relative firefly luciferase activities (normalized to Renilla luciferase activity in the same
samples) of cells transfected with expression vectors carrying the indicated constructs after
treatment with E2 or E2/P4 in phenol red-free EMEM media in 1% charcoal-stripped FBS. Data
are shown as mean and standard error of the mean. N=6 for each treatment group. P<0.001 by
two-way Anova with Dunnett’s multiple comparison test.
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In contrast, whereas E2/P4-exposed cells produced more activity than vehicle-exposed cells
when driven by the WT promoter, E2/P4-exposed cells expressed less activity than vehicleexposed cells when driven by promoters bearing any of the PRE or ERE mutations (Figure 2.5C
and Supp. Figure 2.2). Together, these data suggest that PR regulates NALCN transcriptional
activity, in part, by binding to their respective PRE sites within the NALCN promoter.

2.4 Discussion
Two major regulators of uterine contractility are hormonal signaling and ion channel
activity [4, 6, 32-35, 63-65]. Previously, we showed that NALCN contributes to the leak current
in human myometrial cells and that loss of this channel in mice results in decreased electrical
bursting activity in myometrial tissue, dysfunctional reproductive outcomes, and smaller litter
sizes [32, 33]. Here, we present evidence that NALCN mRNA and protein expression are
downregulated by E2 and upregulated by P4. Additionally, E2 decreased and P4 increased a Na+
conducting and Gd3+-sensitive current that was predominantly carried by NALCN in MSMCs.
We also showed that blocking ER or PR with competitive antagonists blocked the effects of E2
and P4. Finally, mutating the PRE sites in the NALCN promoter region blocked the effects of
P4, suggesting that P4 acts through its nuclear receptors and response element sites to regulate
NALCN transcription. Mutations of the ERE site did not abolish the effect of E2, suggesting that
E2 and ERα work through another mechanism to modulate NALCN transcription.
Our conclusion that NALCN is upregulated by P4, a pro-quiescent hormone, and
downregulated by E2, a pro-contractile hormone, is contrary to the traditional concept that Na+
influx depolarizes the cell to enhance cell excitability. We suggest three potential reasons to
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explain NALCN upregulation by a pro-quiescent hormone during pregnancy. First, when serum
P4 concentration is high, Na+ influx through NALCN may counteract K+ efflux to maintain the
resting membrane potential at ~-60 mV. Consistent with this idea, Lu et al. showed that, in
neurons, NALCN conducted a Na+ background current that opposed the K+ conductance to
maintain the resting membrane potential [40]. Furthermore, we showed that NALCN contributed
to the background leak current in term non-labor human MSMCs [32]. Second, Na+ influx
through NALCN may activate other signaling pathways associated with maintaining resting
membrane potential. For example, K+ efflux through Na+-activated K+ channels has been
reported in MSMCs, and increased NALCN expression and activity may directly activate more
K+ channels, thus making the resting membrane potential more negative and promoting
quiescence [65, 66]. Third, in the presence of increased P4, NALCN and Na+ influx can activate
Na+/K+-ATPase pumps, which are necessary for maintaining the resting membrane potential in
MSMCs [35, 67]. Overall, P4-mediated upregulation of NALCN expression and activity may
contribute to maintaining uterine quiescence by stabilizing the resting membrane potential.
In previous work, we found that in the pregnant mouse uterus, NALCN mRNA and
protein expression were high in early pregnancy, decreased during mid-pregnancy, increased at
labor, and remained high post-partum [33]. The observed NALCN expression in the pregnant
mouse suggests that NALCN protein levels are downregulated by P4 and upregulated by E2,
which differs from what we observe in human myometrium. Yet, in our previous work, we did
not measure P4 and E2 at the time points during pregnancy when we measured NALCN. Thus, a
temporal analysis of NALCN expression and hormone concentrations could help explain the
species-specific differences in hormonal regulation of NALCN.
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Given the role of E2 as a pro-contractile hormone, one might expect that the depolarizing
current through NALCN would increase in the presence of E2, but we found the opposite.
Recent neuronal studies showed that overexpression of NALCN dampened excitability and pain
sensitivity in sensory neurons of mole rats by depolarizing the membrane potential to a value at
which voltage-gated Na+ channels were inactivated [68]. Similarly, in myometrial cells,
increased NALCN expression in the myometrium may indirectly dampen excitability by
inactivating other excitatory channels. If this is the case, then E2 may downregulate NALCN to
maintain the membrane potential at a certain value to ensure that these excitatory channels can
be activated.
Previous evidence has suggested that PRB promotes quiescence by downregulating
expression of inflammatory and contractile-associated genes [5, 15]. At the end of pregnancy,
PRA:PRB ratio increases, leading to functional suppression of PRB, upregulation of
inflammatory and contractile-associated genes, and labor induction [5, 15]. However, we found
that both P4-bound PRA and P4-bound PRB increased NALCN expression. Likewise, Tan et al.
showed that P4-bound PRA and PRB regulate several genes in the same direction, including
bromodomain-containing protein 7, apolipoprotein B editing enzyme catalytic subunit 3B,
protocadherin beta 8, and plasminogen activator, tissue type. These genes are involved in cell
cycle regulation, cellular remodeling, and breakdown of blood clots, which are all necessary for
the entirety of pregnancy [5]. Thus, future efforts could be directed at determining whether
NALCN similarly functions in the cell cycle, cell remodeling, or vasculature events. Regardless,
our data provide another example in which PR-A and PR-B work together to regulate gene
expression.
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Hormone receptors bind to their specific hormone response elements within promoters to
regulate transcription. In our study, mutation of each putative PRE site in the NALCN promoter
caused a decrease in reporter expression. In contrast, mutation of the ERE1/PRE3 site did not
abrogate E2-mediated transcriptional repression. One possibility is that additional ERE sites exist
further upstream than 2.5 kb from the NALCN transcriptional start site. Alternatively, E2-ER
could regulate NALCN expression via interaction with transcription factors, such as Sp1 or AP1, that bind to their own canonical binding sites [69-73]. For example, PR-bound JUN/JUN
homodimer (AP-1 type protein) forms a complex with P54/Sin3A/HDAC and binds to the AP-1
consensus site to regulate Connexin-43 expression in MSMCs [11, 74, 75]. Putative AP-1 and
Sp1 sites have been identified in the NALCN promoter region [54], but whether these sites are
required for ER-dependent NALCN regulation in MSMCs has not been determined.
As pregnancy progresses, concentrations of both E2 and inflammatory mediators increase
[76, 77]. Thus, E2 could down-regulate NALCN indirectly through inflammatory mediators. For
example, in macrophages, the E2-ERα complex upregulates inflammatory mediators such as IL1β and IL-6 and thereby affects genes downstream [78]. Additionally, in the myometrium, IL-1β
regulates expression of channels and transporters (e.g., sarco/endoplasmic reticulum Ca2+ATPase) and increases Ca2+ transients through store-operated calcium entry [79]. Thus, E2-ERα
may upregulate pro-inflammatory mediators in the myometrium, directly affecting NALCN
expression and activity. This could provide an indirect mechanism by which NALCN is
downregulated by E2.
In addition to regulating NALCN expression, E2 and P4 may regulate expression of
accessory subunits that affect NALCN localization and function. For example, in mouse
hippocampal and ventral tegmental area neurons, NALCN activity is modulated by the
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interacting proteins UNC80, NCA Localization-Factor 1 (NLF-1), UNC79, Ca2+ Sensing
Regulator, and Src family kinase [80-82]. UNC80 is of particular interest because it contributes
to the localization and/or stabilization of NALCN at the cell membrane in neurons [82]. UNC80
also provides a scaffold for UNC79 and Src family kinase binding, which leads to activation of
NALCN in various cell types [83]. Additionally, in Drosophila, an UNC80 mutation led to
decreased NALCN protein concentration [84]. We have shown that UNC79 and NLF-1 mRNAs,
but not UNC80, are expressed in uterine samples from term non-laboring women [32]. Thus,
future effort should be directed at determining the effects of pregnancy stage, E2, and P4 on
expression of these NALCN complex components.
In conclusion, this study provides evidence that NALCN is upregulated by P4 and
downregulated by E2 in human myometrial cell lines. Our findings provide a foundation to
further explore the function of NALCN during the quiescent period of pregnancy. For example,
NALCN may play an important role in maintaining resting membrane potential during this
period [32]. In the long term, defining the interplay between hormones and ion channels in the
uterus will allow us to design targeted therapeutic approaches to treat uterine pathophysiology of
pregnancy and labor.
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3.1 Introduction
Electrical activity of myometrial smooth muscle cells (MSMCs) is a key regulator of
uterine contractions. The modulation of uterine electrical and contractile activity are required for
several functions of the female reproductive tract, including contractile waves associated with
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menstrual cycle, transport of sperm for fertilization, implantation of the embryo at the beginning
of pregnancy, and contractility during parturition [1]. Unfortunately, aberrant electrical signaling
can cause unproductive uterine contractions with several health consequences during the
menstrual cycle and during pregnancy. Some of the consequences during pregnancy result in
preterm or post-term deliveries.
As pregnancy progresses from the quiescent state towards term labor, the resting
membrane potential (Vm) of MSMCs undergo a gradual depolarization from -75 mV at the end
of the 2nd trimester to -50 mV at term or at the time of labor. These changes in the Vm are
followed by an increase in the frequency of uterine contractions [2, 3]. The regulation of the Vm
involves multiple ion channels, however the precise identity of the channels involved and how
their activity changes during pregnancy remains unclear. It is well established that the Vm is
determined primarily by an equilibrium between an outward K+ leak current and an inward Na+
leak current across the plasma membrane. The relative magnitude of these currents is regulated
by the membrane permeability/conductance to K+ and Na+ ions. If the membrane permeability to
K+ is increased, the Vm becomes more negative, promoting quiescence. Conversely, when the
permeability to Na+ ions is increased, the Vm becomes more positive, and the uterus is in a more
excitable and contractile state. Thus, identifying the ion channels and the molecular mechanisms
that control the Vm is key in understanding how MSMC excitability and uterine contractions are
regulated.
Our previous studies identified SLO2.1, a member of the SLO2 family of Na+-activated
K+ channels, in human MSMCs [4-6]. This channel has low voltage dependence, high
conductance, and can be significantly active at physiological intracellular Na+ concentration [4,
7]. The characteristics of the channel suggests that SLO2.1 may modulate Vm and cell
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excitability by regulating the membrane permeability to K+. SLO2 channels are also highly
expressed in brain and other smooth muscle cells [6, 8-10], where they form complexes with
voltage-gated Na+ channels to modulate the cell membrane potential [4, 11]. These complexes
allow the Na+ conducted through the Na+ channels to modulate K+ currents and have a greater
effect on the Vm. However, it is unknown if SLO2.1 couples with a Na+ channel to form a
functional complex that can modulate Vm and cell excitability in human MSMCs.
A recent study identified the Na+ Leak channel, non-selective (NALCN) [12]. This
voltage-independent channel conducts about 50% of the sodium leak current at the Vm in human
MSMCs [12]. Overall, these characteristics make NALCN an excellent candidate to be the
source of Na+ to modulate the SLO2.1 channel, but no evidence has been reported about the
existence of this type of complex in human MSMCs. Here we tested the hypothesis, that
NALCN, by forming a complex with the SLO2.1 channel, can be the source of Na+ that
modulates SLO2.1 activity and induce changes in the Vm in human MSMCs. We provide
evidence that SLO2.1 and NALCN comprise a functional complex in human MSMCs that can
regulate MSMC excitability and uterine contraction.

3.2 Methods and Materials
3.2.1 Ethical Approval and Acquisition of Human Samples
This study conformed to the Declaration of Helsinki and was approved by the
Institutional Review Board at Washington University School of Medicine (approval no.
201108143) except for registration in a database. We obtained a signed written consent from
each patient with forms approved by the Washington University in St Louis Internal Review
Board. Human tissue samples from the lower uterine segment were obtained from non-laboring
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women at term (37 weeks of gestation) during elective Cesarean section under spinal anesthesia.
Samples were stored in 4°C in PBS and processed for myometrial smooth muscle cell isolation
within 60 min of acquisition.

3.2.2 Culture of Myometrial Smooth Muscle Cells
Primary cultures of human myometrial cells from tissue samples obtained during
cesarean procedures from women were obtained and cultured as previously described [13].
Briefly, tissue was pre-treated with PBS with 50μg/mL gentamicin and 5μg/ml fungizone. After,
tissues were cut into 2- to 3-mm pieces and cultured in DMEM:F12 medium with 5% Fetal
Bovine Serum (FBS), 0.2% fibroblast growth factor-β, 0.1% epidermal growth factor, 0.05%
insulin, 0.05% gentamicin, and 0.05% fungizone. Colonies were amplified to form primary cell
cultures. Primary MSMCs culture and human telomerase reverse transcriptase-immortalized
myometrial cells (hTERT-HM) were incubated at 37°C and 5% CO2, in phenol–red free
DMEM: F12 medium with 10% FBS, 100 units/ml penicillin and 100 µg/ml streptomycin or 25
μg/mL gentamicin (Sigma, St. Louis, MO). Primary MSMCs were used within two passages and
hTERT-HM cells were used in passages lower than P15 to avoid differentiation.

3.2.3 Electrophysiology
Cells were starved in plain DMEM:F12 for at least for 2 hours prior to experiments. For
all experiments, pipettes were obtained from borosilicate glass from Warner Instruments. For
inside-out macro-patches and whole-cell recording, pipettes with a resistance of 0.8- to 1.8Mega Ohms (MΩ) were used. For single channel recording, the pipettes used were in the range
of 4- to 6- MΩ. For whole-cell recordings with MSMCs and hTERT-HM cells, the external
solutions used (asymmetrical K+, unless specified) were, in mM: 150 NaCl, 5KCl, 5 HEPES,
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and 2 MgCl2, pH adjusted to 7.4 with NaOH. For the 0 mM Na+ solution, Na+ was replaced by
150 mMvCholineCl and KOH was added instead of KCl to regulate the pH at 7.4, the
concentration of external K+ varied from 4.5 to 5.5 mM. The pipettes were filled with (in mM):
140 KCl, 5 HEPES, 0.5 MgCl2, 5 Mg-ATP, with 0.6 mM free Mg2+ and 10 EGTA for the 0 Ca2+
solutions. For pipette solutions with 100 nM Ca2+free we used 1mM EGTA. Inside-out macro
patches and single-channel patch clamp recordings were performed using symmetrical K+
solutions. The internal solution contained (in mM): 80, 140 or 160 KCl, 80 NaCl (or 80
CholineCl for the 0 Na+ condition), and 10 mM HEPES. The pipette solution was in mM: 80,
140 or 160 KCl, 80 NaCl, 2 MgCl2, and 10 HEPES. All with the pH adjusted to 7.2-7.4. Changes
in the solutions are indicated in the figures. During electrophysiological experiments, the cells
and the intracellular side of the membrane were perfused continuously. Traces were acquired
using an Axopatch 200B (Molecular Devices), digitized at 10 kHz for whole cell or macropatches recording or at 100 kHz for single-channel recording. Records were filtered at 2 kHz or
20 kHz for macro currents (whole cell and macro-patches) or single channel recording,
respectively. We analyzed the data with pClamp 10.6 (Molecular Devices) and SigmaPlot 12
(Jandel Scientific).

3.2.4 In Situ Proximity Ligation Assay
The hTERT-HM cells were cultured in chambered slides (8-well; LabTek/Sigma, St.
Louis, MO), serum-deprived in 0.5% FBS for 24 h, washed in ice-cold 1X PBS, and then fixed
in 4% (wt/vol) paraformaldehyde (PFA) in PBS for 20 min at room temperature with gentle
rocking. After 4 x 5-min washed in 1X PBS, cells were permeabilized with 0.1% NP-40 for 5
min at room temperature, washed twice with PBS, and washed once in 100 mM Glycine in PBS
to quench remaining PFA. The slides were rinsed in milliQ water to remove residual salts.
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Duolink in situ proximity ligation assay (Sigma, St. Louis, MO) labeling was performed with
antibodies: NALCN (mouse monoclonal; StressMarq), SLO2.1 (rabbit polyclonal, Alomone).
The manufacture’s protocol was followed completely except that cells with stained with
NucBlue Fixed Cell Stain ReadyProbes (Invitrogen, Carlsbad, CA) for 5 min at room
temperature before final wash in wash buffer B. Slides were dried at room temperature in the
dark, mounted in Vectashield (Vector Laboratories, Burlingame, CA) and stored in the dark at 20 °C until analysis. Images were recorded using a AF 6000LX system from Leica (Buffalo
Grove, IL, USA) with a Leica DMi8000 inverted microscope and a Andor-Zyla-VCS04494
camera. A halogen lamp was used as source of excitation the wavelength, excitation wavelength
used were 488 nm for PLA signals and 340 nm for NucBlue (DAPI). A63X objective (HC PL
FluoTar L 63X/0.70 Dry) was used to obtain the images. Data collection and system control
were done using LasX software from Leica. Acquisition parameters used were: 2 and 1.5
seconds of exposure time for 488 and 340 nm respectively, no binning, 2048 x 2048 pixels
resolution and voxel size of 0.103 μm. Whole images were taken every 10 seconds. Images
analysis was done using LAS X, ImageJ software (National Institutes of Health, Bethesda,
Maryland, USA), and SigmaPlot 12 (Systat Software Inc., Chicago, IL, USA). Results are
presented as punctate per cell. Punctate were counted after background subtraction. All the
imaging experiments were done at room temperature.

3.2.5 Determination of Membrane Potential by Flow Cytometry
hTERT-HM cells were centrifuged at 1000 rpm for 5 min. Cells were resuspended in modified
Ringers solutions: 80 mM Choline Cl, 10 mM HEPES, 5 mM Glucose, 5 mM KCl and 2 mM
CaCl2; pH 7.4). The hTERT-HM cell viability and membrane potential were monitored using
fluorescent dyes, Hoechst 33342 (Cayman, Ann Arbor, MI) and DiSC3(5) (ThermoFisher,
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Waltham, MA), respectively. Hoechst 33342 sorts living cells based on DNA content and
DiSC3(5) is a cationic voltage sensitive dye that follows hyperpolarization and has a emits a
different wavelength based on extracellular or cytoplasmic localization. Here we record
cytoplasmic DiSC3(5) wavelength. Before recording, 0.02 mg/mL Hoechst and 150 nMDiSC 3(5)
was added to 500 µL of cell suspension and data was recorded as individual cellular events using
and FACS Canto II TM cytometer (BD Biosciences, Franklin Lakes, NJ). Side scatter area (SSCA) and forward scatter area (FSC-A) fluorescence data were collected from 100,000 events per
recording. The voltages used to record these fluorescence signals were as follows: FSC (231) and
SSC (386). Threshold levels for FSC and SSC were set to exclude signals from cellular debris
(Figure 3.1A). Doublets, aggregates and additional cell debris were excluded from analysis based
on a dual parameter dot plot, in which pulse signal (signal high; SSC-H; y-axis) versus signal
area (SSC-A; x-axis) was displayed (Figure 3.1B). Living cells that displayed negative staining
for Hoechst was selected by using the filter Pacific Blue (214) and positive cells for DiSC3(5)
were detected using the filter for allophycocyanine (APC; 291) (Figure 3.1C). To establish the
effect of Na+ on membrane potential, 80 mM NaCl, Choline chloride or Lithium (Li+) was added
to the 500 uL suspension. Additionally, 10 μM gadolinium (Gd3+), a concentration known to
inhibit NALCN current [14], 500 nM GsMTx4 (a peptide isolated from Grammostola spatulata
spider venom; blocks TRPC1 and TRPC6), and 1μM Pyr3 (pyrazole; blocks TRPC3) were added
to the cell suspension to determine NALCN’s contribution to the leak currents [14-16].
Normalization was performed by adding 1 µM valinomycin (Sigma, St. Louis, MO). Data
(median values) were analyzed using FlowJo software.
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Figure 3.1: Optimized Parameters for Flow Cytometry.
A) SSC-A and FSC-A light detection were used to identify MSMCs based primarily on size. B)
Singlets were selected with SSC-A and SSC-H to exclude doublets or debris. C) Hoechst dye
was used to differentiate between live and dead MSMCs.
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3.2.6 Calcium Imaging
Cells were culture glass coverslips with the media mentioned before for myometrial
smooth muscle cells. Cells were pre-incubated with 2μM Fluo-4 AM and 0.05-0.1% Pluronic
Acid F-127 in Opti-Mem for 60-90 min. To allow the dye to reach equilibrium in the cells, the
cells were removed from the loading solutions and placed in ringer solution for 10 to 20 minutes.
A perfusion system with an estimate exchange time of 1.5 s applied the various solutions.
Recordings started 2-5 min prior to the addition of the first test solution. Ionomycin (5 μM) was
added at the end of the recordings as a control stimulus. Recordings of the calcium signals were
done with a AF 6000LX system from Leica (Buffalo Grove, IL, USA) was used with a Leica
DMi8000 inverted microscope and an Andor-Zyla-VCS04494 camera. A halogen lamp was used
as source of excitation the wavelength filter for excitation was 488 +/- 20 nm. As objectives a
40X (HC PL FluoTar L 40X/0.70 Dry) or a 20X (N-Plan L 20X/0.35 Dry) air objective were
used. For the emitted light filters a bandwidth of 530 +/- 20 nm were used. Data collection and
system control were done using LasX software from Leica. Acquisition parameters used were:
120 ms of exposure time, 2x2 binning, 512 x 512 pixels resolution and a voxel size of 1.3 μm for
the 20X objective. Whole images were taken every 10 seconds. Images analysis was done using
LAS X, ImageJ software (National Institutes of Health, Bethesda, Maryland, USA )[17],
Clampfit 10 (Molecular Devices) and SigmaPlot 12 (Systat Software Inc., Chicago, IL, USA).
[Ca2+]i changes are presented as (F/FIono) after background subtraction. All the imaging
experiments were done at room temperature. Cells with [Ca2+]i changes of 5-10% relative to
ionomycin responses changes were counted as responsive.

75

3.2.7 Isometric Tension Recording
Human myometrial tissue from four non-laboring women at term were isolated and cut
into strips and immediately placed in 4° Krebs solution containing (in mM): 133 NaCl, 4.7 KCl,
1.2 MgSO4, 1.2 KH2PO4, 10 TES, 1.2 CaCl2, and 11.1 glucose, pH 7.4. Strips were mounted to a
force transducer in organ baths filled with oxygenated (95% O2, 5% CO2) Krebs solution at
35.7°C, and tension was recorded by a muscle strip myograph system - 820MS (DMT, Ann
Arbor, MI) data acquisition system. Basal tension (2 g) was applied to the tissue strips and
equilibrated for 1 hr prior until spontaneous myometrial contractility appeared. When four stable
regular contractile waveforms were observed, we changed the Krebs solution to modified Krebs
(lower [Na+] solution containing (in mM): 33.25 NaCl, 99.75 CholineCl, 4.7 KCl, 1.2 MgSO4,
1.2 KH2PO4, 10 TES, 1.2 CaCl2, and 11.1 glucose, pH 7.4. Tension was recorded for 30 min.
Traces obtained in the last 10 minutes before and after modified Krebs solution addition were
compared using LabChart 8 (ADInstruments, Colorado Springs, CO). Basal tension and area
under the curve (AUC) of phasic contractions of the e myometrial strips was calculated in both
solutions.

3.2.8 Statistical analysis
Statistical analysis was performed using Sigmaplot, version 12.0 (Systat Software Inc.).
An unpaired Student’s t test was used to determine significant differences between independent
samples tested. A paired t test was used to determine significant differences in case–control
studies performed in the same individuals. Results are expressed as the mean ± SD. P < 0.05 was
considered statistically significant.
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3.3 Results
3.3.1 The Gd3+ sensitive, Na+ leak current is the source of Na+ for the Na+-activated
K+ current in human MSMCs
Here we investigate the source of the Na+ that regulates SLO2.1, the previously described
Na+-activated K+ channel that can regulate the excitability of the cell by changing the Vm [18]. In
order to isolate the responses related to SLO2.1 channels, we used the SLO1 K+ channel blocker
tetraethylammonium (TEA) (5–10 mM) [19]. After adding 80 mM extracellular Na+ to evaluate
the activation of SLO2.1 current, we measured an 80-100% increase in the currents at +80 mV
and -60 mV (Vm) (Figure 3.2A, D and E). An influx of extracellular Na+ can activate KNa
channels at Vm as shown in Figure 1A and previously in human MSMCs by us [18] and also in
neurons [4, 11]. To investigate if the recently described Na+ leak channel, NALCN [12] conducts
the Na+ responsible for the activation of SLO2.1 in MSMCs, we performed whole-cell patch
clamp experiments with controlled intracellular solution and different Na+ channel blockers.
When experiments are performed in the presence of gadolinium (Gd3+), a known blocker
of sodium leak channels, the Na+-dependent K+ current is not activated by the addition of
extracellular Na+ (Figure 3.2B, D and E). This indicates that the source of Na+ that activates KNa
in human MSMCs is conducted by a Na+ leak current. We confirmed that Gd3+does not have a
direct effect on SLO2.1 channels (Figure 3.3). Thus, these results confirm that the Na+ source to
activate KNa in human MSMCs is driven by a Na+ leak current, which could be conducted by
NALCN.
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Figure 3.2: SLO2.1 channels are activated by a NALCN-Dependent Gd3+ sensitive Na+ leak
current in human MSMCs.
A) Schematic of whole-cell recording set-up. B) Representative whole-cell currents (Vh = −70
mV, with step pulses from −80 to +150 mV) from human MSMC recorded in the absence
(control) and presence of 80mM Na+.The Na+-dependent currents were calculated by subtracting
traces (80 mM –0 mM Na+). C) Same as B, in the presence of 10 μM Gd3+. Graph D and E: The
percentage of Na+-dependent currents activated with the addition of 80 mM Na+ at +80 mV and 60 mV, respectively (n = 5 cells, data plotted as the mean ± SD). Values are for control at -60
mV: mean= 89.24, SD= 63.56 and at +80 mV: mean= 94.75, SD= 77.14. Values with Gd3+ at -60
mV: mean= 3.51, SD= 23.50 and at +80 mV: mean= 11.20, SD= 16.36. Unpaired t-test was
performed.* P-Value<0.05.
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Figure 3.3: Effects of Gd3+ over SLO2.1 Currents.
A, schematic of whole-cell recording set-up and voltage steps applied. B) Representative wholecell currents (Vh = −70 mV, with step pulses from −80 to +150 mV) from human MSMC
recorded in the absence (control) and presence of 20 μM Gd3+. The subtraction of traces
represent: 0 – 20 μM Gd3+and 20 μM Gd3+-0. C.: Graph currents in the presence of 20 μM
Gd3+at -60 and +80 mV voltage steps, normalized to currents in control, error bars are SD.
Values: 1) at -60 mV, Mean=1.03, SD= 0.195 and n= 6. 2) at 80mV, Mean= 1.018, SD= 0.0814
and n= 6. Paired t-test were performed and P-Value are 0.739 and 0.589 for 1 and 2,
respectively.
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3.3.2 NALCN and SLO2.1 are in close proximity in human MSMCs
Studies have confirmed the expression of functional complexes between SLO2.1 and
sodium channels that activate SLO2.1 currents at Vm in neurons [4, 11]. To determine if NALCN
and SLO2.1 channels are in proximity, we performed in situ proximity ligation assay in both
human primary MSMCs and hTERT-HM. Punctate green fluorescent signals were detected and
quantified in cells exposed to antibodies specific to NALCN and SLO2.1 (Figure 3.4A, B, and
C). No significant signals were detected in our negative controls: 1) NALCN antibody alone, 2)
SLO2.1 antibody alone or 3) secondary antibody alone (Figure 3.4A, B, and C). This data
confirms that NALCN and SLO2.1 are expressed in close proximity in human MSMCs.

3.3.3 Hyperpolarization of the Vm induced by SLO2.1 activity is modulated by a
NALCN-dependent Na+ leak current
We investigated if an increase in the NALCN-dependent Na+ leak current induced by the
addition of extracellular Na+ could modulate the Vm due to changes induced in SLO2.1 activity.
To measure the changes in Vm, we used DiSC3(5) fluorescence in flow cytometry. DiSC3(5) is a
cationic voltage sensitive dye that accumulates on hyperpolarized membranes and increases
intracellular fluorescence. To evaluate the effects of extracellular Na+, we treated the cells with:
1) sodium, 2) choline, an impermeable cation to maintain osmolarity or 3) lithium (Li +), a
permeable cation that does not activate SLO2.1 channels.
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Figure 3.4: NALCN and SLO2.1 are in proximity in human MSMCs cells.
A) Representative PLA labeling of hTERT-HM and human MSMCs with the indicated single
Abs and Ab combinations. (Scale bar, 10 μm.) (B,C) Average number of PLA signals in hTERTHM (N=4) and human MSMCs cells, respectively. Human MSMC experiments were replicated
in primary cultures from term non-laboring patients (N=4). Over 300 cells per condition were
processed. Data are presented as mean and standard deviation. *P<0.05, and ***P<0.001 by
unpaired t-test.
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There was a significantly higher hyperpolarization when cells were treated with Na+ than
when treated with either choline or Li+ (30.48% ± 20.62, 9.91% ± 9.76, and 2.01% ± 6.54,
respectively) (Figure 3.5A and B). Therefore, Na+ influx causes a hyperpolarization in the
membrane potential of MSMCs presumably by activating SLO2.1.
To determine if Na+ flux through NALCN was the main source of Na+, we measured the
hyperpolarization induced in the presence of the Gd3+, a blocker of NALCN. Hyperpolarization
induced by the addition of Na+ in cells treated with Gd3+ was decreased to 6.01% ± 7.16 (Figure
3.5A and B). This response was similar to the hyperpolarization measured in cells treated with
choline or Li+ (P-value of 0.163 and 0.662, respectively) (Figure 3.5A and B). Similarly, in the
presence of Gd3+, there was no significant change in the hyperpolarization in cells treated with
choline or sodium (mean(s) of 5.63% ± 4.57 vs 6.01%, respectively and P-value of 0.833) (
Figure 3.6A).
Although, Gd3+blocks NALCN currents, it also inhibits transient receptor potential
canonical channels (TRPC). TRPC1, 3 and 6 channels were previously identified in human
MSMCs [20-24]. TRPCs are primarily Ca2+ conducting channels, but they can conduct Na+ [2024]. We evaluated if the influx of Na+ through TRPC channels could modulate SLO2.1 activity
and Vm by using GsMTx-4 and Pyr3, two inhibitors that block TRPC 1 and 6 and TRPC 3,
respectively. The hyperpolarization induced in cells by extracellular Na+ and TRPC blockers was
lower than in cells treated with Na+ alone (17.77% ± 12.10 vs 30.48%, P-value of 0.040) (Figure
3.5A and B). Yet, in the presence of TRPC blockers, Na+ induced a higher hyperpolarization
than choline (mean(s) of 17.77% vs 5.21% ± 6.426, respectively, P-value of 0.008) (Figure
3.6B).
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Figure 3.5: Regulation of SLO2.1 activity by the NALCN-dependent Na+ leak induces
hyperpolarization of the Vm.
A. Representative images of experimental schemes and relative shifts of DiSC3(5) fluorescence
induced by Sodium, Choline, Lithium, GsMTx-4 and Pyr3 and Gd3+ in hTERT-HM cells. B)
Quantification of shifts in cells by Sodium (n= 18), Choline (n=15), Lithium (n=6), Sodium
(GsMTx-4 and Pyr3; n=9) and Sodium (Gd3+; n=5) normalized to changes in Valinomycin
fluorescence. Data are presented as mean and Standard deviation. *P<0.05, **P<0.01,
***P<0.001 by unpaired t-test with Mann-Whitney corrections.
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Figure 3.6: Gadolinium blocks hyperpolarization caused by both extracellular Na+ and
Choline while TRPC blockers partially decrease the hyperpolarization caused by
extracellular Na+.
A) Quantification of shifts in cells by Sodium (Gd3+; n= 5) and Choline (Gd3+, n=6) normalized
to changes in Valinomycin fluorescence. B) Quantification of shifts in cells by Sodium (GsMTx4 and Pyr3; n=9) and Choline (GsMTx-4 and Pyr3; n=7) normalized to changes in Valinomycin
fluorescence. Data are presented as mean and standard error of the mean. **P<0.01byunpaired ttest with Mann-Whitney corrections.

84

Additionally, the decrease in hyperpolarization induced by extracellular Na+ was greater in the
presence of Gd3+ than the TRPC blockers (6.01% vs 17.77%, P-value of 0.029) (Figure 3.5A and
B). Our data indicate that the NALCN-dependent Na+ leak current is responsible for ~60% of the
Na+-dependent hyperpolarization in human MSMCs, while the combination of TRPC 1, 3, and 6
contributes to ~40% of this hyperpolarization.

3.3.4 Functional coupling of the NALCN/SLO2.1 modulates intracellular Ca2+
responses in human MSMCs
Membrane depolarization triggers intracellular calcium increases through VDCCs in
human MSMCs. Ferreira et al suggested that the inhibition of SLO2.1 channels by oxytocin or
PMA triggers Ca2+ entry through VDCCs [18], possibly by modifying the membrane potential.
We confirmed that the regulation of NALCN/SLO2.1 complex by extracellular Na+ changes the
Vm in human MSMCs. We hypothesized that NALCN-dependent Na+ leak currents, by
modulating SLO2.1 channels, can regulate VDCC and the intracellular calcium levels in
MSMCs. We performed experiments measuring the intracellular calcium concentration by using
the Ca2+ indicator Fluo4-AM. First, we used 5, 10, 20, and 50 mM KCl to induce increasing
levels of membrane depolarization and observed that 20 and 50 mM KCl induced intracellular
Ca2+ increases (Figure 3.7A).
Next, to evaluate the effects of extracellular Na+, we substituted with Choline or with Li+
[7, 25, 26]. In Figure 3.7B, cells were incubated in 80 mM Na+ and 80 mM Choline, and then
Na+ component of the solution was replaced with 80 mM choline (160 mM choline). This change
in the extracellular solution caused Ca2+ oscillations (Figure 3.7B and C) is comparable to those
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Figure 3.7: Na+ leak regulates intracellular calcium homeostasis and basal tension in
human MSMCs and myometrial tissue.
A, B, D and E. Representative fluorescence traces from human MSMCs loaded with 10 μM
Fluo-4 AM. A) Membrane depolarization responses to 5, 10, 20, and 50 mM external KCl. B and
C) Calcium responses induced by substituting extracellular Na+ with Choline or Li+ respectively.
Graph I shows the quantification of the area under the curve (AUC) of the first 5 min after
changing the solutions. Values are: 8.19 +/- 8.9 (SD), n=21; 61.5 +/- 43.6 (SD), n=10; and 80.3
+/- 55.8 (SD), n=9; for Na+, Choline, and Li+ respectively. D) Calcium responses induced by
substituting extracellular Na+ with Li+ in 0 mM external Ca2+ and 2 mM EGTA. Graph II shows
basal intracellular calcium levels (5 min AUC) of cells bathed for at least 20 min with 135 mM
Na+, 135 mM Li+ or Li+ with EGTA. Values are: 7.0 +/- 7.7 (SD), n=21; 34.2 +/- 22.9 (SD),
n=10; and 6.94 +/- 6.7 (SD), n=4; for Na+, Li+, and Li++EGTA respectively. All recordings were
normalized to the fluorescence in 5 μM ionomycin and 2 mM extracellular Ca2+ (Iono). E)
Representative tension-recording trace of myometrial tissue obtained from TNL patient in
normal and low extracellular Na+. Figure H, quantification of basal tension when tissue was
bathed with control (red) or low Na+ (blue) solutions (Error bars = SEM). Figure I, quantification
of area under the curve (AUC) when tissue was bathed with control (green) or low Na+ (light
brown) solutions (Error bars = SEM). For Figures C and F unpaired t-test was performed and in
Figure H and I, paired t-test were performed, n=4 for both. * P-Value<0.05, ** P-Value<0.01,
and *** P-Value<0.001
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Supplementary Figure 3.8: Na+ leak regulates intracellular calcium homeostasis and basal
tension in human MSMCs and myometrial tissue.
Representative fluorescence traces from human MSMCs loaded with 10 μM Fluo-4 AM.
Calcium responses in MSMCs by substituting extracellular Choline with Na+. Reverse
experiments of Figure 3.4B.
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induced by 50 mM KCl (Figure 3.7A). To avoid possible effects of using a non-permeable cation
(choline), we performed experiments using Li+ as a substitute for Na+, which does not activate
SLO2.1. In Figure 3.7D, cells were incubated in 135 mM Na+, and then replaced with 135 mM
Li+. This change in the extracellular solution induced statistically significant Ca2+ increases
(Figure 3.7C and D) similar to the responses triggered by 160mM choline (Figure 3.7B) and 50
mM KCl (Figure 4A). We observed similar results when cells were incubated with 160 mM
choline and then replaced 80 mM of the choline solution with 80 mM Na+ ( Figure 3.8). To
confirm that the Ca2+ increases induced by SLO2.1 inhibition are dependent on VDCCs and
extracellular Ca2+, we repeated the Li+ experiment in the absence of 0 mM Ca2+ and 2 mM
EGTA. No intracellular Ca2+ increases were observed under these conditions (Figure 3.7E).
Increases in the basal levels of intracellular Ca2+ were measured when Na+ was replaced
with either Choline or Li+ (Figure 3.7F). These results are in line with our hypothesis where the
absence of Na+ would inhibit SLO2.1, depolarize the MSMCs, activate VDCCs and increase
basal Ca2+ levels. To investigate if these findings translated to changes in basal tension and
contractility, we performed tension recording on myometrial strips obtained from term non-labor
patients. In Figure 3.7G, we show a representative trace of a myometrial strip bathed in normal
Krebs solution that contains 133 mM Na+ (control). When the extracellular Na+ was reduced
from 133 mM to 33.25mM, there was a significant increase in both the basal (0.61 ± 0.15 g vs
2.51 ± 0.68 g) and total (AUC) (219 ± 113 g vs 1118 ± 366.4 g) tension produced by the
myometrial strips (Figures 3.7H and I). NALCN/SLO2.1 complex by extracellular Na+ can
modulate intracellular Ca2+ responses in human MSMCs and these effects can be observed in the
tension generated by myometrial tissue. Together these results confirm that the regulation of the
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NALCN/SLO2.1 complex by extracellular Na+ can modulate intracellular Ca2+ responses in
human MSMCs and these effects can be observed in the contractile activity of the uterus.

3.4 Discussion
Our results support the idea of a novel complex between a NALCN-dependent Na+ leak
current and the SLO2.1 channel modulating the Vm and the myometrial smooth muscle
excitability. In patch clamp, we showed that the inhibition of the NALCN-dependent Na+ leak
current by Gd3+ reduced the activation of the Na+-activated current carried by the SLO2.1
channel (Figures 3.2 and 3.3). With proximity ligation assays, we confirmed the close proximity
of NALCN and SLO2.1 (Figure 3.4). We found that the increase in the inward Na+ leak current
induces a hyperpolarization of the Vm in human MSMCs (Figures 3.5 and 3.6). Finally, we
provide evidence that the modulation of the Vm by NALCN-dependent Na+ leak current and
SLO2.1 channels can increase intracellular calcium by opening VDCC (Figures 3.7 and 3.8).
In MSMCs, action potentials are driven by an influx of Ca2+ through VDCC that open in
response to a slow recurrent depolarization between action potentials (pacemaker current) [2730]. Previous works in dopaminergic neurons and gastrointestinal cells showed that the
depolarizing Na+ leak currents could contribute to the pacemaker activity [31-33]. Although
NALCN, a Na+ leak channel, has been identified in MSMCs, the role of this channel [12, 34,
35], in regulating the pacemaker activity is still not well understood. If the channel is involved in
setting the pacemaker activity, the absence of NALCN should present with a disrupted interburst frequency of action potentials. Yet, Reinl et al. only observed a significant reduction in the
burst duration and no significant differences in myometrial inter-burst frequency at day 19 of
pregnancy in NALCN KO mice [35]. These results and other recent studies have suggested that
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NALCN could have a role in regulating myometrial excitability presumably by modulating
the permeability of other ions (particularly K+) and the Vm in MSMCs [12, 18, 35].
Different K+ channels including the inward rectifier Kir7.1, Ca2+-activated Maxi-K, and
Na+-activated SLO2.1 channels have been identified in human MSMCs [18, 19, 39, 40]. The
expression of the Kir7.1 channel peaks in mid-pregnancy in mice and Kir7.1 currents contribute
to maintaining a hyperpolarized Vm and low contractility during the quiescence state of
pregnancy in mice and humans [39]. This suggests that Kir7.1 could contribute to regulating the
transition from the quiescent to the contractile state during pregnancy. Yet, Ferreira et al. showed
that Maxi-K and SLO2.1 contribute to ~87% of the K+ current in human MSMCs (52% and
35%, respectively) [18]. Additionally, the authors showed that SLO2.1 is regulated by Na+ and
conducts current at the Vm of these cells [18], thus this channel introduces a novel mechanism to
regulate the Vm, excitability and contractility of human MSMCs. Here we provide data showing
the possible modulation of SLO2.1 channels by NALCN by demonstrating that the potassium
channel SLO2.1 can be activated by an inward Gd3+-sensitive Na+ leak current (Figures 3.2 and
3.3). These results confirmed that a NALCN-dependent leak current can be the source of Na+ to
activate the SLO2.1 channel. This novel mechanism could regulate the Vm by increasing both the
permeability to K+ and the hyperpolarizing conductance of the cell.
In order for NALCN and SLO2.1 to be physiologically important as a functional
complex, these two channels need to be in close proximity. By being in close proximity, the Na+
leak current (NALCN) can modify the Na+ concentration several fold in the intracellular
microdomain without changing the bulk intracellular Na+ concentration [4, 10]. We showed
using in situ proximity ligation assay that NALCN and SLO2.1 are within 40 nM of each other in
human MSMCs, confirming the close proximity of the two channels (Figure 3.4). These results
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support the possibility of NALCN and SLO2.1 functioning as a complex and provide another
example of functional complexes, which has already been found between many channels,
including SLO2 channels and Nav1.6 in neurons [4, 11].
We investigated if the inward NALCN-dependent Na+ leak current induces changes in
the Vm by increasing the outward K+ current carried by SLO2.1. Our hypothesis was that due to
the proximity of the channels and the different conductance of NALCN (14.6 pS/pF) and SLO2.1
(78 pS), an increase in the inward Na+ leak current that activates the SLO2.1 channel would
cause a global cell hyperpolarization [12, 18]. We measured the membrane potential of
myometrial cells and the results demonstrated that the addition of extracellular Na+ causes a
hyperpolarization of the Vm, supporting our hypothesis (Figure 3.5). Due to the limitations of the
experimental conditions, we corroborate that membrane potential results are not a consequence
of: 1) changes of the osmolarity when 160 mosm are added or 2) an increase in the cationic
inward current. When 80 mM LiCl, a permeable cation that does not activate the SLO2.1 channel
was added the Vm remained unchanged (Figure 3.3B). The hyperpolarization induced by
extracellular Na+ was abrogated in the presence of Gadolinium (Gd3+), an inhibitor of Na+ leak
currents (Figures 3.5 and 3.6) [12, 14]. In the presence of Gd3+, the cell becomes almost
impermeable to Na+ and the addition of 80 mM NaCl under this condition induced a small
hyperpolarization that we attributed to osmolarity changes. We observed a similar percentage of
hyperpolarization when Na+ was substituted with Choline, an impermeable cation.
Gadolinium blocks both NALCN and transient receptor potential canonical channels
(TRPC) channels [36, 37]. Several TRPCs, including TRPC1, TRPC3, and TRPC6, can conduct
both Ca2+ and Na+ and have different levels of expression in uterine tissue from rats and humans
[20-24]. To determine if these three channels can contribute to the regulation of the Na+91

activated K+ current carried by SLO2.1, we used GsMTx-4 and Pyr3, specific blockers for TRPC
1/6 and TRPC 3, respectively. The results led us to the conclusion that TRPC1, 3 and 6
contribute ~40% of the hyperpolarization induced by the addition of 80 mM extracellular Na+
(Figures 3.5 and 3.6). This highlights that the NALCN-dependent Na+ leak current contributes to
~60% of the hyperpolarization induced under these conditions. The exact regulation and role of
TRPCs channels during pregnancy is still under investigation. On one hand, the expression of
TRPC6 (mRNA and Protein) is downregulated, while TRPC1 expression has no major difference
in expression during pregnancy in rats [20]. On the other hand, TRPCs channels are sensitive to
multiple signals in vitro, including mechanical stretch and IL-1β, signals notable important
during labor [21, 38, 39]. Our results suggest that TRPC 1, 3 and 6 channels could have a role in
regulating the Vm, but based on previous evidence these channels may have a higher impact
during labor when tension in the myometrium is increased. Further investigation is needed to
understand the exact role of these channels during pregnancy.
We recently published evidence showing that oxytocin acting through a non-canonical
pathway inhibits the SLO2.1 channel and induces an increase in intracellular Ca2+ by opening
VDCC in human MSMCs [18]. These results are in line with data published by Arnaudeau et al.
that suggested oxytocin has a sustained effect over the intracellular Ca2+ concentration that is
also dependent on VDCC activity in MSMCs from pregnant rats [40]. We attributed this
activation of VDCC to the depolarization induced by the inhibition of the SLO2.1 channel [18].
Here we show that the modulation of the NALCN-dependent Na+ leak current has similar effects
over the activity of VDCC and intracellular Ca2+ concentration (Figure 3.7 and 3.8). In our
results, the absence of extracellular Na+ increases both the transients and sustained levels of
intracellular Ca2+ (Figures 3.7 and 3.8). By using Ca2+ free extracellular solution, we confirmed
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that the responses induced by the absence of extracellular Na+ are dependent on extracellular
Ca2+ conducted through VDCC (Figures 3.7 and 3.8). Until here, we showed that NALCN and
SLO2.1 by their role as a functional complex can regulate intracellular Ca2+ levels by modifying
the Vm. We also observed that the reduction of extracellular Na+ increased the contractility levels
produced by human myometrium muscle (Figures 3.7 and 3.8). In MSMCs, contraction is
initiated when intracellular Ca2+ ions bind to calmodulin, a Ca2+-dependent cytosolic protein
[41]. Thus, these results corroborate the novel importance of NALCN and SLO2.1 functional
complex in the regulation of MSMC excitability and contractility.
It is known that ion channel activity and hormonal signaling are two major regulators of
uterine contractility [12, 18, 35, 42-47]. Our novel model in Figure 3.9 shows how progesterone
(P4), estrogen (E2) and oxytocin (OXT) could modulate MSMCs excitability, by regulating the
expression and activity of NALCN and SLO2.1 complex. First during the quiescent state, P4
upregulates the expression of NALCN channels [47]. We hypothesize that this would increase
the NALCN-dependent Na+ leak current, which activates SLO2.1 channels, hyperpolarizes the
cell and closes VDCCs in human MSMCs. Second, during the contractile state, OXT can induce
calcium release from intracellular stores, and inhibit SLO2.1 channels acting through PKC [18]
(Figure 3.9). The inhibition of SLO2.1 channels during the contractile state will be potentiated
by the downregulation of NALCN by E2, a pro-contractile hormone [47]. Thus, we propose that
OXT and E2, by inhibiting SLO2.1 channels in the last stages of pregnancy, will cause a
depolarization of human MSMCs, promote intracellular Ca2+ increase through VDCC and
increase uterine contraction (Figure 3.9). In summary, our model proposes novel insights into the
mechanisms of how pregnancy hormones can modulate the activity of NALCN and the SLO2.1
channel and MSMC excitability levels during different stages of pregnancy.
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Figure 3.9: Proposed model for the hormonal regulation of NALCN/SLO2.1 complex in
regulating myometrial excitability.
During the quiescent state progesterone binding to PRA/B increases the expression of NALCN
channels [47]. Sodium current through NALCN activates SLO2.1 channels, increasing the K+
current to maintain the cell negativity so the voltage-dependent Ca2+ channels (VDCC) are
closed and uterine contractions do not occur. Our data together with previous publications from
our laboratories [18, 47] suggest that the Na+-activated K+ current (SLO2.1 channels) that
maintain the MSMC resting membrane potential in the presence of Na+ flux. In the contractile
state, estrogen acting on ERα inhibits the expression of NALCN channels [47]. A decrease in
NALCN activity prevents SLO2.1 activity resulting in depolarization. VDCC are more active
when the membrane depolarization increases, increasing intracellular Ca2+, which can promote
uterine contractions. Also, close to labor OXT binds OXTR, increasing diacylglycerol (DAG)
that activates protein kinase C (PKC), which inhibits SLO2.1 [18]. Further inhibition of SLO2.1
channels could greatly depolarize the membrane, thus opening more VDCCs, which will greatly
increase intracellular Ca2+ and activate myosin to cause muscle contraction.
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Chapter 4: Discussion and Proposed Future
Directions

4.1 The Field of Myometrial Physiology
The electrical activity of myometrial cells, including resting membrane potential (Vm)
and action potential, are caused by controlled changes in membrane permeability to Ca2+, K+,
Na+ and Cl- ions [1, 2]. The changes in the permeability primarily result from changes in both
expression and activity of the myriad of ion channels that conduct these ions [1, 2]. The
myometrial ion channels are classified under five major types: Ca2+, K+, Cl-, Na+ and nonselective channels [1-3]. Historically, studies have primarily focused on Ca2+ (L-Type and TType) and K+ (Ca2+-activated) channels because of their significant contributions to the
depolarizing and repolarizing phases of action potentials, respectively, that modulate the
concentration of intracellular Ca2+ [4, 5]. The major Ca2+ channels are activated by voltage,
while the Ca2+-activated K+ channels are activated by an increase in intracellular Ca2+,
depolarization of the plasma membrane, and uterine relaxants, including β-adrenergic agents,
which elevate cAMP in myometrial cells [1, 6, 7]. Inwardly rectifying and voltage-gated K+
channels contribute to the hyperpolarization of Vm in MSMCs [8, 9]. Functionally, Na+ channels
produce fast inward currents that result in depolarization but their identification and role in
uterine excitability is still being investigated [4, 5]. Finally, Cl- channels and non-selective
channels have been identified and are proposed to regulate the pacemaker activity of the
myometrial cells [4, 9, 10].
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However, fewer studies have delved into the role(s) and regulation of non-selective Na+
channels in MSMC excitability. In my thesis work, I investigated the hormonal regulation of
NALCN, a Na+ leak channel and discovered a novel role for this channel in regulating Vm and
excitability in myometrial smooth muscle cells. My research has answered necessary questions
in the field of myometrial physiology and revealed new questions for further investigation.

4.2 Hormonal Regulation of the NALCN Complex in
MSMCs
Myometrial excitability changes across pregnancy in response to the changing hormonal
expression and activity. Two hormones necessary for these important changes are progesterone
(P4) and estrogen (E2). Progesterone works primarily through the nuclear progesterone receptor
B (PR-B) to maintain uterine quiescence. The P4-PR-B complex downregulates contractileassociated proteins (CAPs) and inflammatory molecules, while upregulating pro-quiescent
proteins and anti-inflammatory molecules [11-20] (Chapter 1). The transition from quiescence to
contractility requires an increase of P4 signaling through PR-A and membrane bound PRs and
E2 signaling through ERα [12, 18, 19, 21-27]. Both of these hormonal changes upregulate CAPs
and inflammatory molecules, leading to increased contractility [20, 27-32] (Chapter 1).
As human pregnancy transitions from quiescence to contractility, the ratio of the proquiescent PR isoform PR-B to the pro-contractile isoform PR-A decreases [18, 32, 33]. Before
term, the PR-B: PR-A ratio is 3:1; this changes to 1:1 during term non-labor (TNL) and to 1:3
during term labor (TL) [32, 33]. These changes remove the inhibitory actions of P4 and PR-B on
CAPs and inflammatory molecules. In my studies, treating HM6ERMS2 cells with E2 induced a
1:1 PR-B:PR-A ratio which resembled the hormone receptor expression observed in TNL
samples (Chapter 2). In this environment, I hypothesized that NALCN would be downregulated
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by P4 and upregulated by E2 since Na+ influx depolarizes the cell and enhances cell excitability.
However, I found that the expression and activity of NALCN in human MSMCs was upregulated
by P4 and downregulated by E2 (Chapter 2). Since P4 is a pro-quiescent hormone, these results
suggest that Na+ influx could promote quiescence. Although these results were unexpected,
NALCN, unlike other major Na+ channels, is constitutively active, voltage insensitive, and
conducts Na+ current at the negative Vm in human MSMCs [34]. Thus, our results are the first to
establish the hormonal regulation of NALCN and suggest a novel role of NALCN in promoting
quiescence during the TNL period of pregnancy.
One limitation in the HM6ERMS2 cell line is that we could not create a PR-B:PR-A ratio
of 3:1 to effectively study the effects of NALCN in a TL-like environment. To address this
limitation in future studies, we can use human myometrial tissue and isolated primary MSMCs
from both TNL and TL samples. Our preliminary experiments show a decrease in baseline
NALCN protein expression in membranes from TL uterine samples (n=3) compared to TNL
uterine samples (n=2) (Figure 4.1). The differences observed in the data could be due to: 1)
variabilities in the patient demographics within each group (TNL and TL), 2) any potential
medications taken by the patient that may affect channel expression and/or 3) differences in
cytokine/inflammatory profile at time of acquisition since cytokines can directly affect ion
channel expression [35-37]. To address these problems, future experiments including: 1)
increasing the sample size of tissue to determine baseline levels of NALCN expression, 2)
evaluating the PR-B:PR-A ratios in each sample, and 3) isolating and treating primary MSMCs
from these tissue samples with exogenous E2 and P4 to study the changes in NALCN expression
from baseline are needed.
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Figure 4.1 NALCN protein expression in primary human myometrial tissue from TNL and
TL patients.
A) Representative Western blot of NALCN in myometrial membrane preparations from term,
non-laboring (TNL) and term laboring (TL) samples. GAPDH served as loading control. B)
Quantification of NALCN protein in the in the TNL (n=2) and TL (n=3) myometrial samples.
NALCN was normalized to GAPDH.

101

NALCN has been shown to interact and form complexes with other proteins to regulate
channel activity in various cell types [38-40]. Thus, E2 and P4 may modulate the expression of
these accessory subunits (Chapter 1). This regulation can then affect the expression, stability
and/or activity of NALCN. As described in detail in chapter 1, the modulation of NALCN in
neurons depends on two proposed scaffolding subunits, UNC79 and UNC80 [38, 40, 41]. Our
lab previously showed that UNC79 but not UNC80 was expressed in uterine samples from TNL
women [34], while unpublished data showed that UNC80 was expressed in myometrial tissue
from non-pregnant and TL samples. I investigated whether E2 and/or P4 modulated UNC79 or
UNC80 expression in the HM6ERMS2 cell line, a line derived from TNL tissue. Preliminary
quantitative RT-PCR revealed that UNC79 mRNA expression increased 2.0-fold in the presence
of E2 and no additional increase was observed in the presence of P4 (Figure 4.2A). I further
showed that P4 had no effect on UNC79 expression in hTERT-HM PR-Flag cells expressing
either PR-A or PR-B (Figure 4.2B). The preliminary data shows that E2 upregulates while P4
does not affect UNC79 expression, which is different from NALCN regulation. In addition,
UNC79 requires UNC80 to modulate NALCN activity in neurons [41] but UNC80 expression
was negligible in the HM6ERMS2 myometrial cell line, a TNL-like environment (data not
shown). In neurons, NALCN conducts a basal Na+ leak current but its sensitivity to changes in
extracellular Ca2+ requires UNC79 and UNC80 current [39]. Thus, UNC79 and UNC80 may be
necessary during labor were the role and effects of Ca2+ are important however, this hypothesis
needs further investigation.
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Figure 4.2 UNC79 and SLO2.1 are regulated by estrogen and progesterone in HM6ERMS2
myometrial cells, respectively.
A) Quantification of quantitative RT-PCR of UNC79 mRNA in HM6ERMS2 treated with
vehicle (N=4), E2 (N=4), E2/P4 (N=4), and P4 (N=4). B) Quantification of quantitative RT-PCR
of UNC79 mRNA in hTERT PR-Flag cells as indicated; N=3 for Empty vector, PRA and PRB
conditions. C) Quantification of quantitative RT-PCR of SLO2.1 mRNA in HM6ERMS2 treated
with vehicle (N=4), E2 (N=4), E2/P4 (N=4), and P4 (N=4). The geometric means of TOP1,
SDHA, and ACTA2 were used as standards for quantification.
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In Chapter 3, we proposed that SLO2.1 functionally couples and interacts with NALCN
in human MSMCs to promote uterine quiescence by contributing to the Vm of the cell and
decreasing intracellular Ca2+. Thus, we investigated if E2 and P4 modulate this novel component
of the NALCN complex in human myometrial cells. Preliminary evidence showed that E2/P4
treatment increased SLO2.1 expression 2.0-fold, similar to NALCN regulation, while E2 alone
had no effect (Figure 4.2C). The upregulation of SLO2.1 and NALCN by P4 suggests an
increased expression of NALCN, which could lead to increased activity of the functional
complex, possibly during the quiescent period. Although, E2 inhibits NALCN, it does not affect
SLO2.1 expression at the transcriptional level. Estrogen may still modulate SLO2.1 channel
activity and/or stability at the membrane, which could affect the functional coupling during the
pro-laboring period. For example, in cardiac cells, the hERG channel (the human Ether-à-go-goRelated Gene) contributes to the rapid delayed rectifier K+ current (Ikr) in the action potential,
which helps to coordinate the beating of the heart [42, 43]. Estrogen inhibits the trafficking of
hERG to the membrane and the Ikr resulting in a decrease in hyperpolarization and a subsequent
increase in excitability in cardiac cells [44, 45]. Oxytocin another pro-labor hormone regulates
SLO2.1 channels in a similar way [46]. Ferreira et al. showed that oxytocin inhibits SLO2.1
activity through the protein kinase C (PKC) pathway, increasing intracellular Ca2+ and
promoting contractions in human MSMCs [46]. Thus, E2 and oxytocin may work in similar
ways leading to a depolarized membrane and increased myometrial activity during the laboring
period, but this needs further investigation. Overall, we have shown that the major pregnancy
hormones dynamically regulate the NALCN complex, which can affect the activity of NALCN
channels in the myometrial cells.
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4.3 The Novel Roles of Sodium Channels in Myometrial
Physiology
Myometrial quiescence depends on the maintenance of a negative Vm in order to prevent
increases in intracellular Ca2+ and subsequent myometrial contractions. Maintaining this negative
Vm in MSMCs requires efflux of K+ ions and the influx of Na+ ions, primarily through K+ and
Na+ channels, respectively. Recently, Ferreira et al. identified SLO2.1, Na+-activated K+
channel, as a potential significant contributor to the maintenance of Vm in human MSMCs [46].
SLO2.1 activation depends on the influx of Na+, which we propose may occur through NALCN.
Several lines of evidence support this model. First, NALCN is a voltage insensitive and
constitutively active channel, meaning it can work at the Vm and possibly help maintain it [34,
47]. Second, our lab recently established that NALCN contributed ~50% of the background
sodium leak current in human MSMCs [34]. Third, the upregulation of NALCN expression and
activity by P4, a pro-quiescent hormone, provides a novel role of NALCN during the quiescent
period [48]. As described extensively in Chapter 3, our results revealed a NALCN-dependent
leak current that contributed to the Vm and modulated intracellular Ca2+, through SLO2.1
activation.
This thesis work identified NALCN and SLO2.1 as channels that could contribute to the
Vm in human MSMCs in similar mechanisms as the inwardly rectifying K+ channel (Kir7.1),
another regulator of Vm [8, 9]. At an expression level, Kir7.1 expression is high in midpregnancy but decreases towards labor in mouse model, similarly to the serum P4 levels,
suggesting that P4 may promote the expression and activity of Kir7.1 [8]. Functionally, both
Kir7.1 and NALCN remain persistently open, which can contribute to a hyperpolarized Vm [8].
Thus, the inhibition of both Kir7.1 and indirectly SLO2.1, by decreasing NALCN activity, can
cause a depolarization, calcium entry and increased contractility in human myometrium [8].
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Thus, we suggest that NALCN and SLO2.1 complex, in addition to Kir7.1, may be important in
regulating the transition from uterine quiescence to contractility and could be targets for
therapeutics to modulate uterine contractility, but further investigation is needed.
Our work also provides insight into the role and regulation of TRPC channels, a Gd3+sensitive, Na+-conducting channel [47, 49, 50]. In our study, we found that a Gd3+-sensitive Na+
current, possibly NALCN and/or TRPCs, contributed to a hyperpolarization of the membrane
potential in human MSMCs. To investigate the contribution of TRPCs to this current, we treated
the human MSMCs with two TRPC inhibitors that blocked TRPC 1, 3 and 6. We saw a ~40%
decrease in hyperpolarization induced by extracellular Na+ suggesting that TRPCs can conduct
Na+ and modulate SLO2.1 channels in human MSMCs. During pregnancy, TRPC channels
increase towards labor, and are activated by mechanical stretch and contribute to the
electromechanical coupling in MSMCs, two events that underlie labor [51-55]. On the other
hand, NALCN is inhibited by E2, a pro-labor hormone, suggesting that NALCN expression and
activity may be decreased during labor. Thus, I hypothesize that NALCN is the primary activator
of SLO2.1 during the quiescent period, while, TRPC is the major activator during the laboring
period of pregnancy, yet further studies are recommended.
Although, this study focused on the channels that could regulate Vm, Na+ conductance
through NALCN and TRPC channels may also regulate myometrial activity in labor through
upstream signaling by uterine contractile agonists, such as substance P [56-60]. Substance P
works through the GPCR neurokinin 1 receptor (NK1R) to activate a Na+ current through
NALCN, which results in rhythmic stability and pacemaking activity, in neurons and interstitial
cells of Cajal (ICCs), respectively [41, 61, 62]. In neurons, this modulation is dependent on the
presence of NALCN and UNC-80 [41, 61]. Since UNC80 and NALCN are present in human TL
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samples, SP may activate NALCN to promote depolarization during the laboring period of
pregnancy and regulate pacemaking activity of action potentials (phase three). Similarly, SP
through NK1R induces an inward Na+ current through TRPC channels to modulate pain
transmission and respiratory rhythm regularity in neurons and this current is inhibited by PKC
[63, 64]. PKC is downstream of NK1R and oxytocin receptor activation. Thus, better
understanding if the PKC-mediated inhibition of TRPC channels may be a negative feedback
mechanism to prevent over-excitation of myometrial excitability by SP or oxytocin during labor
is necessary.
Overall, this thesis work proposes novels roles for Na+ entry through NALCN and TRPC
channels, which can lead to several impacts on myometrial reproductive physiology and provide
a basis to explore similar functional complexes in other excitable organs.

4.4 The Role of NALCN in Translational Studies
We extensively discussed the genetic mutations of NALCN that were found in children
and resulted in neurological and/or respiratory deficits (Chapter 1). These human mutations
demonstrate the crucial role of NALCN in normal neurologic function and development. Yet,
this thesis focused on the role of NALCN in myometrial and reproductive physiology. Thus, it
would be important to discover and study if mutations and/or variants in the human NALCN gene
could significantly affect myometrial or reproductive outcomes. We were recently contacted by a
Norwegian research group, led by Dr. Mbarek, that performed a genome wide association study
(GWAS) to identify SNPs associated with gestational duration in a sample of 7353 twin and nontwin births from the Netherlands Twin Register (unpublished data). They found one noncoding
SNP upstream of the NALCN gene that was associated with gestational duration with genome
wide significance (unpublished data). However, the mechanism of action of this SNP is unclear.
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Further candidate gene studies may be helpful to determine whether variants in NALCN are
important in reproductive outcomes. Once further genes are identified, we can perform
functional studies to assess NALCN expression, stability and activity using mouse models,
CRISPR genome editing and/or myometrial cell lines. The genetics studies coupled with
functional experiments can help us determine whether variants in NALCN are associated with
reproductive pathophysiological outcomes of patients, such as preterm birth and dystocia.

4.5 Concluding Remarks
Pregnancy is a complex physiological event that requires intricate regulation of
quiescence until term and timely onset of contractility at term. The mechanisms and timing rely
on many different regulators, which include hormonal regulation and ion channel activity. Thus,
it is important that when addressing pathological events in pregnancy, we have a better
understanding of the physiology that underlies a successful pregnancy.
In our studies, we were the first establish that NALCN expression and activity are
upregulated by P4 and downregulated by E2. We also discovered a novel functional complex
between NALCN and SLO2.1, a Na+-activated K+ channel, which could be important during the
quiescent period of pregnancy to maintain a negative Vm and reduce intracellular Ca2+. In the
future, it will be important to characterize the hormonal regulation and role of ancillary subunits
of NALCN in myometrial physiology. Additionally, future investigators should determine
whether other Na+ channels in the myometrium can also work through SLO2.1 to maintain the
myometrial Vm. Additionally, determining the effect of genetic variants on NALCN functional
complex activity could help predict reproductive outcomes.
Our findings of a novel regulation and role of NALCN in contributing to uterine
quiescence can provide an opportunity to develop therapeutics that can modulate uterine
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excitability and contractility. Most importantly, these findings can develop many new questions
to address and further the field of myometrial physiology.
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